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ABSTRACT 
Beating neonatal heart cell cultures were treated with 
diamide or t-butyl hydroperoxide, and changes in glutathione 
oxidation, cell beating, and protein S-thiolation (protein 
mixed-disulfide formation) were examined. Both compounds 
caused extensive oxidation of glutathione. Cells treated 
with diamide stopped beating within 2 min, and beating 
returned to normal after 30-45 min. Cells stopped beating 25 
min after addition of t-butyl hydroperoxide, and beating did 
not resume. t-Butyl hydroperoxide caused S-thiolation of a 
variety of proteins, but only one protein, of molecular mass 
23 kDa, was extensively modified. Diamide caused extensive 
modification of proteins with molecular masses of 97, 42, and 
23 kDa as well as three proteins of about 35 kDa. Though the 
GSSG content of cell cultures returned to normal by 15 min 
after diamide treatment, S-thiolation of several proteins 
persisted. These studies show that S-thiolation of proteins 
is an important metabolic response in cells exposed to an 
oxidative challenge by t-butyl hydroperoxide or diamide, and 
that the specificity of the response depends on the agent 
used. 
Two methods for quantitation of protein S-thiolation, by 
isoelectric focusing or by enzymo activity after reaction 
with NEM, were used for studying S-thiolation of cytoplasmic 
V 
cardiac creatine kinase. Both methods were suitable for 
analysis of bovine heart samples, but the activity assay was 
superior for rat heart. With these methods, creatine kinase 
was identified as a major S-thiolated protein in both bovine 
and rat heart. S-Thiolation of creatine kinase with GSSG 
led to inhibition of enzyme activity. In rat heart cell 
cultures, creatine kinase became 8% S-thiolated during a 10 
minute incubation with 0.2 mM diamide. This enzyme became 
S-thiolated more slowly than other heart cell proteins and 
it also dethiolated more slowly. When two sequential 
additions of 0.2 mM diamide were made at a 25 minute 
interval, the second addition produced twice as much 
S-thiolation as the first. This increased sensitivity to 
the second diamide treatment may have resulted from 
glutathione loss during the first addition, which produced a 
higher GSSG to GSH ratio after the second treatment. This 
study demonstrates that cytoplasmic creatine kinase is 
inhibited by S-thiolation during a diamide-induced oxidative 
stress in heart cells. Implications of these results for 
cardiac function during reperfusion injury are discussed. 
vi 
LIST OF ABBREVIATIONS 
BSA bovine serum albumin 
DTT dithiothreitol 
EDTA ethylenediaminetetraacetic acid 
EGTA ethyleneglycol-bis-(aminoethylether 
<N,N,N',N'-tetraacetic acid)) 
GSH glutathione, reduced form 
GSSG glutathione disulfide 
HEPES hydroxyethylpiperazine ethane sulfonic acid 
lAA iodoacetic acid 
lAH iodoacetamide 
NAD+ nicotimamide adenine dinucieotide 
oxidized form 
NADP+ nicotimamide adenine dinucieotide phosphate, 
oxidized form 
NADPH nicotimamide adenine dinucieotide phosphate, 
reduced form 
NEM N-ethyl maleimide 
TCA trichloroacetic acid 
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NOMENCLATURE 
Dlamlde 
Diamide (diazenedlcarboxylic acid bis<N,N-dimethyl-
amide)) oxidizes sul£hydryls to disulfides in a two step 
reaction. During the first step, diamide reacts with the 
sulfhydryl to form an activated intermediate. 
O O 
B II 
(CH3)2NCN=NCN(CH3)2 + RSH > 
O 0 
B II 
<CH3)2NCÇ-NCN<CH3)2 
H SR 
The activated form then reacts with a second sulfhydryl to 
form a disulfide and reduced diamide. 
O Q 
H H 
<CH3>2NCN-NCN<CH3)2 + RSH 
H SR 
O O 
If II 
<CH3>2NCN-NCN<CH3)2 + RSSR 
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INTRODUCTION 
Covalent. modification of proteins is well established as 
one of the principle mechanisms for regulation of metabolism. 
Both in. vitro and in. vivo studies suggest that protein 
S-thiolation (formation of mixed-disulfides between proteins 
and low molecular weight thiols such as glutathione) [1] may 
be an important mechanism for regulation of metabolism. 
S-Thiolated proteins can arise through simple exchange 
reactions with low molecular weight disulfides. 
Protein-SH + RSSR i 1 Protein-SSR + RSH (1) 
The rate of the spontaneous reaction is usually slow at 
physiological pH because the deprotonated form of the 
sulfhydryl is involved in exchange. The most likely low 
molecular weight disulfide for the reaction in cells is 
glutathione disulfide (GSSG). Glutathione is present in high 
concentrations in cells C2] and a mechanism for producing 
GSSG in cells is well established (see the section on 
oxidative stress below). Enzymatic formation of S-thiolated 
proteins through catalysis of the exchange reaction shown 
above has been proposed. An enzyme catalyzing 
thiol-disulfide exchange was first described by Racker C33. 
This enzyme, now called thioltransferase [4] has been 
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extensively studied [4-8]. This enzyme has been shown to 
dethiolate proteins, and may be involved in S-thiolation of 
some proteins as well C73. 
Our laboratory has been interested in the possibility 
that S-thiolation of proteins plays a role in regulation of 
metabolism in heart. This section will introduce some of the 
evidence, both from in, vitro and from in. vivo studies, that 
suggests S-thiolation is an important regulatory mechanism in 
many tissues. It describes specific conditions in which 
S-thiolation may be important in heart. 
S-Thiolated Proteins and Metabolic Regulation 
For S-thiolation to be a regulatory mechanism in 
metabolism, the changes which occur when proteins become 
S-thiolated must cause coordinated changes in metabolic 
pathways. That is, S-thiolation should activate some 
pathways while inhibiting others in a manner that produces an 
overall change in metabolism. In. vitro studies of individual 
enzymes whose activity are changed by S-thiolation indicate 
that coordinated changes in metabolic pathways should occur 
if proteins become S-thiolated. A wide variety of proteins 
have their activity altered by S-thiolation. This discussion 
will deal with some of the more important enzymes which are 
modified by S-thiolation and will show why these 
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modifications support the concept of S-thiolation as a 
mechanism of general metabolic regulation. Several recent 
reviews [9-11] provide additional information. 
From in. vitro studies, it appears that S-thiolation may 
play a role in mobilizing cellular energy stores for the 
formation of cytoplasmic reducing potential, in the form of 
NADPH. Enzymes involved in this type of regulation fall into 
three categories. Many enzymes which utilize cellular energy 
for biosynthesis are inhibited. Enzymes of carbohydrate 
metabolism are altered such that utilization of energy is 
inhibited and pathways which ultimately produce 
glucose-6-phosphate are activated. The pentose phosphate 
pathway is activated by S-thiolation of glucose-S-phosphate 
dehydrogenase. Each of these classes of enzymes will be 
discussed separately. 
There are many examples of biosynthetic enzymes which 
are inhibited by S-thiolation. These include 
S-hydroxy-S-methylglutaryl-coenzyme A reductase [12,13], the 
committed step in cholesterol biosynthesis; indoleamine 
N-acetyl transferase [11,14], involved in melatonin 
biosynthesis; ornithine decarboxylase [15], in polyamine 
synthesis; ATP-citrate lyase [16,17], in supply of cytosolic 
acetyl CoA for a variety of biosyntheses, including fatty 
acids; and fatty acid synthase [9,18]. In addition. 
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eukariotie initiation factor 2 can become inhibited through 
S-thiolation, inhibiting protein synthesis [19,203. Thus, 
S-thiolation of proteins could inactivate a variety of 
cellular biosynthetic pathways. 
The second group of enzymes of interest are those 
involved in carbohydrate metabolism. Alterations in these 
pathways often involve pairs of enzymes, one of which is 
activated and the other inhibited to result in decreased 
utilization or storage of carbohydrate and an increased 
production of glucose-6-phosphate. Two examples where 
S-thiolation may be involved in this type of regulation are 
the reactions of glycogen synthase - glycogen phosphorylase 
and phosphofructokinase - fructose-l,6-bisphosphatase. 
Regulation of glycogen metabolism is complex. A primary 
means of regulation of glycogen metabolism is through 
phosphorylation and dephosphorylation of glycogen synthase 
and glycogen phosphorylase. S-Thiolation could also play a 
role in regulation of these enzymes. Glycogen synthase is 
directly inhibited by S-thiolation [21-243. Glycogen 
phosphorylase is indirectly activated by S-thiolation. 
S-Thiolation inhibits phosphorylase phosphatase [25-271 which 
leads to conversion of phosphorylase b to phosphorylase a. 
Thus, S-thiolation may promote glycogenolysis and inhibit 
glycogen synthesis. 
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Glycolytic pathways of the cell may be regulated at two 
points by S-thiolation, the interconversion of fructose-1,6-
bisphosphate and fructose-&-phosphate and the conversion of 
phosphoenolpyruvate to pyruvate. Phosphofructokinase and 
fructose-l,6-bisphoGphatase catalyze the first of these 
conversions. Both are highly regulated enzymes. Activity of 
these two enzymes is important in switching between 
glycolysis and gluconeogenesis. S-Thiolation could play a 
direct role in regulation of these two key enzymes. 
Phosphofructokinase is inhibited by S-thiolation [9,28,29]. 
Fructose-1,6-bisphosphatase has been reported to be activated 
by S-thiolation [30-37]. The mechanism of activation 
involves a decrease in inhibition of the enzyme by AMP. The 
earlier studies [30-35] are somewhat controversial since the 
enzyme used may have been partially degraded by proteolysis 
during preparation [34,35]. More recent studies [36, 373 
indicate the non-proteolyzed enzyme is also activated by 
S-thiolation. Recently, Hoser et al. [38] isolated two forms 
of the enzyme from rat liver. One form could be converted to 
the other by thiol reduction. The oxidized form was less 
inhibited by AMP than the reduced form. It was not 
determined if the oxidized form was an S-thiolated form of 
the enzyme. Thus, S-thiolation can potentially inhibit 
glycolysis and promote gluconeogenesis. 
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Another glycolytic enzyme, pyruvate kinase, is also 
inhibited by S-thiolation [7,39]. This is of particular 
significance because, in one of these studies Z72 the enzyme 
could be S-thiolated enzymatically by cytoplasmic 
thioltransferase. The overall effect of S-thiolation on 
pathways of carbohydrate metabolism is to promote formation 
of glucose-6-phosphate from glycogen and glycolytic 
intermediates. 
One of the most compelling arguments in favor of 
S-thiolation as a regulatory mechanism comes from the work of 
Eggleston and Krebs on glucose-6-phosphate dehydrogenase 
[40]. Glucose-6-phosphate dehydrogenase is the rate limiting 
enzyme of the pentose phosphate pathway, and is the major 
source of cytoplasmic NADPH [41]. The NADPH/NADP+ ratio is a 
primary control mechanism for activity of this enzyme, and 
ratios greater than about 10 lead to nearly complete 
inhibition of the enzyme. Previous studies by Veech, 
Eggleston, and Krebs [42] show that cytoplasmic NADPH/NADP+ 
ratios are about 100. Eggleston and Krebs [40] sought for a 
metabolic activator of the enzyme which could relieve this 
inhibition. Of over 100 compounds tested, only incubation 
with GSSG could alleviate the inhibition. Thus, S-thiolation 
nay play a critical role in control of the pentose phosphate 
pathway. 
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Thus, ill. vit.ro studies indicate that S-thiolation could 
play an important role in regulation of metabolism in. vivo. 
A variety of in. vivo studies also support this hypothesis. A 
discussion of some of the problems involved with in. vivo 
studies of S-thiolation is necessary prior to discussion of 
these studies. Three topics will be addressed, the source of 
cytoplasmic disulfides for formation of S-thiolated proteins, 
the problem of artifactual thiol oxidation, and the 
techniques used for in. vivo S-thiolation studies. 
Oxidative Stress 
The cytoplasm of cells is a highly reduced environment 
[42]. Oxidative stress is a term used to describe a wide 
variety of conditions in which the cellular balance is 
shifted to a more oxidized state. Oxidative stress is 
characterized by an increase in reduced oxygen species in the 
tissue. These include superoxide anion, hydrogen peroxide, 
hydroxyl radical, and many organic oxygen radicals and 
peroxides C433. These species may produce a variety of 
alterations in the cell, including DMA damage C443 and lipid 
peroxidation [45], which directly damage cells. Enzymatic 
detoxification of many of these reduced oxygen products is 
mediated by three enzyme systems, superoxide dismutase, 
catalase, and glutathione peroxidase. Superoxide dismutase 
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rapidly converts two molecules of superoxide to one molecule 
of oxygen and one molecule of hydrogen peroxide [46]. 
Superoxide dismutases are present in all cells, and are 
usually quite active. Hydrogen peroxide can be generated by 
cellular metabolism [47,46] or by dismutation of superoxide 
during oxidative stress. Degradation of hydrogen peroxide in 
cells proceeds by one of two pathways, either through 
catalase or glutathione peroxidase. Catalase activity is 
limited to the peroxisomes of most cells, and cytoplasmic 
reduction of hydrogen peroxide is primarily accomplished by 
glutathione peroxidase [49]. This is of extreme importance 
in the S-thiolation of proteins because glutathione 
peroxidase provides the mechanism by which oxidative stress 
can increase the concentration of GSSG in cells. Glutathione 
peroxidase catalyzes the reduction of both hydrogen peroxide 
and many organic peroxides to produce water or an alcohol 
plus GSSG 
ROOH ROH 
2 GSH f HOOH ) GSSG + H2O + yoH (2) 
GSSG can also be formed directly during oxidative stress, by 
reactions with organic radicals [50]. 
GSH + R-
GS • *• GS • 
» GS- + RH 
» GSSG (3) 
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The GSSG produced by these reactions is available to 
S-thiolate proteins or can be reduced by glutathione 
reductase using NADPH. Thus, in the presence of reduced 
oxygen species, a mechanism for production of GSSG has been 
well studied. 
A variety of conditions can produce oxidative stress. 
In heart, the most important mechanisms are probably 
metabolism of drugs, reperfusion after ischemia, and the 
oxidative burst of neutrophils during inflammation. 
Adriamycin (doxorubicin) and daunomycin (daunorubicin) 
are widely used anthracycline antineoplastic drugs [51,523. 
They have been effectively used in treatment of leukemia, 
lymphomas, breast cancer, ovarian cancer, lung cancer, 
Hodgkin's disease, and soft tissue sarcomas. The limiting 
factor in use of these drugs is cardiotoxicity. It has been 
proposed that one possible mechanism by which the drug 
damages heart is through production of reduced oxygen species 
[53-65]. The mechanism proposed involves a redox cycle in 
which a one-electron reduction of the quinone of the drug to 
a semi-quinone is catalyzed by microsomal [55,56] and 
mitochondrial [53,54,59-62] enzymes. Semi-quinones react 
rapidly with available oxygen to produce superoxide [62,63] 
and regenerate the quinone. Thus, redox cycling of 
anthracyclines, and of quinones in general [62,66-69] can 
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produce large amounts of superoxide in cells. Heart may be 
especially susceptible to these effects due to the abundance 
of mitochondria [52]. A specific inhibitor of glutathione 
reductase, l,3-bis<2-chloroethyl)-1-nitrosourea (BCNU) [70], 
has been used to study the effects of adriamycin on cells 
[71,723. These studies showed that inhibition of glutathione 
reductase lead to increased toxic effects of adriamycin and 
loss of glutathione from both cytoplasm and mitochondria of 
cells. Thus, substantial evidence indicates that 
anthracycline toxicity in heart may be mediated through 
superoxide formation. Evidence that inhibition of 
glutathione reductase enhances the toxic effects of 
adriamycin indicates that increases in GSSG occur during 
adriamycin toxicity. 
Reperfusion injury in heart and other tissues is a 
condition which occurs following ischemia. Ischemia is a 
condition in which blood flow to a tissue is interrupted, 
resulting in loss of oxygen supply, nutrient delivery, and 
waste removal. Cells can recover from short periods of 
ischemia. Extended ischemia results in metabolic changes in 
cells which cause irreversible damage. These changes are 
primarily caused by increases in reduced oxygen species in 
heart during reperfusion. Two changes in cell metabolism 
during anoxia prime the cell for reoxygenation damage. 
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First, lack of oxygen as an electron acceptor results in 
reduction of all electron carriers in the electron transport 
chain [73]. During reperfusion» reduced electron carriers 
can produce reduced oxygen species either by direct reaction 
with oxygen or by reduction of compounds which produce redox 
cycling (as anthracyclines, discussed above). Second, heart 
is almost totally dependent on aerobic metabolism for energy 
production. Anaerobic glycolysis can produce less than lO % 
of the minimum ATP required to maintain cardiac function 
[74,753. Hypoxia during ischemia leads to rapid depletion of 
high energy phosphate pools in heart. Irreversible ischemic 
damage is characterized by decreases of creatine phosphate to 
less than 2% of normal values, decreases of ATP to less than 
10% of normal values, a shutdown of glycolysis, and 
conversion of greater than 75% of the adenine nucleotide pool 
to nucleosides and bases, primarily inosine and hypoxanthine 
[76]. Upon reperfusion, xanthine oxidase can convert 
hypoxanthine to xanthine with the production of superoxide. 
Xanthine dehydrogenase is rapidly converted to the oxygenase 
form during reperfusion [73]. Radical formation as a result 
of superoxide production is one cause of the damage to the 
tissue and radical scavengers can be effective in reduction 
of reperfusion injury [76-80]. Thus, reperfusion of ischemic 
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heart may lead to conditions in which reduced oxygen species 
are significantly increased. 
The oxidative burst of neutrophilic granulocytes is 
known to produce large quantities of a variety of reduced 
oxygen species C503. There is no doubt that these species 
can produce oxidative stress in nearby cells. The question 
here is whether neutrophil invasion of heart tissue is 
important. Several studies have indicated that activated 
neutrophils and their associated oxidative stress may play a 
key role in oxidative damage during reperfusion injury in 
heart. The presence of inflammation and neutrophil 
infiltration into ischemic myocardium has been well 
documented. It has been conclusively shown that removal of 
neutrophils during reperfusion greatly decreases the extent 
of reperfusion damage in ischemic heart [81]. The effects of 
neutrophil removal may not be entirely due to removal of 
oxidative products, however. Neutrophils can bind to damaged 
endothelial cells, blocking capillaries and preventing 
reperfusion of local tissue. However, antiinflammatory 
agents also decrease reperfusion damage [82,83], indicating 
that activation of neutrophils is probably important in 
reperfusion damage. The signal which draws neutrophils to 
damaged myocardium has not been determined with certainty. 
Components of the complement system are found in ischemic 
13 
heart [81,843. It is probable that either reduced oxygen 
species produced during reperfusion or products released by 
damage caused by these molecules are responsible for the 
chenotactic signal which triggers neutrophil infiltration. 
Thus, activated neutrophils may contribute significantly to 
oxidative stress in reperfused heart tissue. 
A number of conditions can lead to oxidative stress in 
heart. All of these conditions would be expected to produce 
increases in GSSG in heart cells, as this is the primary 
route of detoxification of reduced oxygen species. Increased 
GSSG in cells may lead to S-thiolation of proteins and 
alteration of metabolism. 
Technical Problems in Studies of S-Thiolation 
The greatest problem in investigation of protein 
S-thiolation and glutathione oxidation status in cells is the 
spontaneous oxidation of glutathione (and other thiols) to 
disulfides during sample preparation. This reaction is 
catalyzed by transition metal ions, especially iron, in the 
presence of oxygen C413. A variety of methods which prevent 
artifactual oxidation of thiols have been developed for 
analysis of both GSSG [85-88] and S-thiolated proteins [893. 
The methods for analysis for GSSG rely on the rapid reaction 
of N-ethyl maleimide (NEM) at neutral pH to block free 
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thiols, preventing oxidation. Methods for analysis of 
protein S-thiolation either use NEM to block thiols or use 
extraction of proteins in acid, followed by resolublization 
and reduction. Acidic conditions inhibit artifactual 
S-thiolation. In spite of available methods, a large number 
of widely cited studies present data for GSSG and protein 
S-thiolation which were determined without considering 
artifactual oxidation C2,90-933. As a result, methodology 
used in determination of GSSG and S-thiolated proteins must 
be carefully examined in any paper where such data is 
reported, and studies which do not preclude artifactual 
oxidation of thiols must be considered incorrect. 
A frequently used method for determination of 
S-thiolated proteins has been to acid-extract tissue, 
resuspend the protein, reduce the bound mixed-disulfides, and 
quantitate the released thiols. A common method for 
quantitation is the use of o-phthalaldehyde to produce a 
fluorescent adduct of the released thiols [89,94-973. This 
reaction was shown to be fairly specific for GSH in tissue 
extracts [86], and so was assumed to be specific for GSH 
released from S-thiolated proteins. Brigelius et al. [893 
have shown conclusively that this assumption is incorrect. 
In this study, released thiols from acid-precipitated 
proteins of liver were determined by several different 
15 
enzymatic methods, or by o-phthalaldehyde fluorescence. The 
fluorescence assay produced values which were 5 times the 
amount of GSH actually released from protein. The nature of 
the interfering material was not determined. Similar 
problems have been reported for determination of GSSG by this 
method [98]. Thus, a number of studies on S-thiolation of 
proteins by glutathione contain values which are incorrectly 
high. These studies may still provide useful insight into 
effects of S-thiolation on metabolism, but the magnitude of 
S-thiolation measured by this method is uncertain. 
Techniques for Studying S-Thiolation 
As discussed in the oxidative stress section above, GSSG 
is the probable precursor to S-thiolation of proteins. 
Hydrogen peroxide and glutathione peroxidase act to produce 
increased GSSG in cells, which may lead to S-thiolation of 
proteins [47]. Because of the complexities of peroxide 
reactions in cells, and the instability of hydrogen peroxide, 
model compounds have been extensively used in the study of 
the thiol redox state and protein S-thiolation in cells [99]. 
Two compound have been extensively used in modeling oxidative 
stress in a wide variety of cells and tissues. t-Butyl 
hydroperoxide has been used in studies of intact organs, 
tissues, and cells, and is a model for the enzymatic 
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formation of GSSG in cells [100]. t-Butyl hydroperoxide is a 
substrate for glutathione peroxidase, but not catalase, and 
can produce GSSG in a manner similar to hydrogen peroxide. 
The second widely used compound is diamide (diazenedi-
carboxylic acid bis<N,N'-dimethylamide)) [2,101,102] which 
chemically oxidizes thiols to disulfides (see page vii). In 
addition to these two agents, compounds which undergo redox 
cycling to produce oxidative stress have been studied. The 
herbicide paraquat exhibits this type of effect [97] as well 
as the antineoplastic drug, Adriamycin, discussed earlier. A 
specific inhibitor of glutathione reductase, N,N'-bis 
<2-chloroethyl)-N-nitrosourea (BCNU) has been useful in 
determining the role of GSSG in oxidative stress [70-72,103]. 
Host studies on effects of oxidative stress on 
metabolism have not determined protein S-thiolation. 
Alterations in metabolism which occur have been related to 
the expected alterations resulting from S-thiolation studies 
of purified proteins, and the presence of S-thiolated 
proteins has been implied from this correlation. In studies 
where S-thiolation of proteins was determined, reducible 
thiols on proteins were correlated with alterations of 
metabolism. With two exceptions noted below, S-thiolation of 
specific proteins in. vivo was never demonstrated prior to the 
studies presented in this dissertation. The two exceptions 
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are the work o£ Haest et al. C1043 and the previous work from 
our laboratory by Grimm et al. Cl]. Both groups developed 
methods for determination of S-thiolated proteins by 
SDS-polyacrylamide gel electrophoresis under conditions which 
prevented artifactual S-thiolation. Haest et al. determined 
erythrocyte membrane protein S-thiolation in response to 
diamide using ^H-glycine to label the glutathione pool of 
erythrocytes. Grimm et al. determined S-thiolation of heart 
cell cytosolic proteins in response to diamide using 
35S-cystine to label the heart cell glutathione pool. NEM 
was used to prevent artifactual S-thiolation during sample 
preparation by Grimm et al. but not by Haest et al. In both 
methods the glutathione pool was radioactively labeled and 
S-thiolated proteins were determined by autoradiography of 
gels. In heart cells, protein synthesis was inhibited with 
cycloheximide during radioactive labeling of glutathione. 
Since erythrocytes do not synthesize proteins, no inhibitors 
of protein synthesis were required. 
In Vivo S-Thiolation of Proteins 
Oxidative stress in cells and tissues produces a variety 
of effects. Changes which have been attributed to 
S-thiolation of proteins will be stressed in the current 
discussion. It should be pointed out that many of the toxic 
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effects of oxidative stress are related to lipid peroxidation 
and the resulting breakdown of cell membranes £453. These 
effects will not be dealt with extensively in the current 
discussion. 
Oxidative stress has been shown to increase GSSG in a 
variety of tissues using a variety of agents (see [2,9-11,99] 
for current reviews). Increases in S-thiolated proteins have 
also been reported in response to oxidative stress in liver 
[89,96], lung [97], heart cells [1], erythrocytes [104,1053, 
and other tissues [2]. Activation of the pentose phosphate 
pathway, presumably through S-thiolation of glucose-6-
phosphate dehydrogenase, has been reported in lung during 
paraquat toxicity [97,1063, and this activation correlated 
with increased concentrations of S-thiolated proteins [973. 
Pentose phosphate pathway activation has also been reported 
in brown fat cells [1073, adipocytes [1083, perfused liver 
£10,109,1103 and heart [1113. In one-of these studies, 
nutritional state of the animal had an effect on 
susceptibility of tissue to oxidative stress. Brigelius 
£1103 showed that livers from fasted rats exhibited greater 
GSSG levels and pentose phosphate pathway activation in 
response to t-butyl hydroperoxide perfusion than did livers 
from normally fed animals. The differences were attributed 
to decreased concentrations of GSH in fasted animals. The 
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effects of increased GSSG on glucose-6-phosphate 
dehydrogenase is two-fold. The enzyme is strongly inhibited 
by NADPH- C403. In addition to activation by S-thiolation, 
increased GSSG can decrease NADPH concentrations by providing 
substrate for glutathione reductase. Both mechanisms are 
involved in activation of the pentose phosphate pathway 
during oxidative stress CIO,40]. 
Increases in glycogenolysis and gluconeogenesis have 
also been reported during oxidative stress (see CIO]). An 
increase in phosphorylase a content of skeletal muscle during 
diamide-induced oxidative stress has been reported C112] . 
This activation has been attributed to an inhibition of 
phosphorylase phosphatase C25-27]. 
Xanthine oxidase in cells is normally active as a 
NAD"^-utilizing dehydrogenase. During oxidative stress, it is 
converted to an oxidase form which uses molecular oxygen and 
produces superoxide C73,113]. This conversion is now 
believed to be the result of S-thiolation of the enzyme 
[114]. This is of particular importance in heart, where 
xanthine oxidase may play a key role in oxidative stress 
during post-ischemic reperfusion. 
An additional factor which may play a crucial role in 
S-thiolation of heart proteins during oxidative stress 
involves GSSG efflux from cells. Elevation of GSSG levels 
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leads to loss of GSSG from cells. This has been observed in 
liver [100,115,116], heart [117], the eye lens, and 
erythrocytes [105,118,1193. The efflux of GSSG from heart is 
a saturable effect, indicating that a carrier is present and 
that, in heart but not in liver, rate of export can be 
limited by carrier availability. Thus, heart may have 
increased concentrations of GSSG during oxidative stress due 
to a slowed export of GSSG. 
In vivo studies of altered metabolism during oxidative 
stress induced by a variety of compounds indicate that 
S-thiolation of proteins could play an important role in 
metabolic regulation during oxidative stress. The studies 
cited above show support for S-thiolation in heart during 
oxidative stress. Little has been said about differences 
between agents which promote oxidative stress. The evidence 
available from the literature indicates that diamide, t-butyl 
hydroperoxide, and agents such as paraquat, all produce 
similar changes in glutathione oxidation, protein 
S-thiolation and activation of the pentose phosphate pathway. 
Few studies have looked for differences in response to 
different agents. Studies which have directly compared 
effects of t-butyl hydroperoxide and diamide, for example 
[103], have usually emphasized quantitative differences in 
the effects of the two agents rather than qualitative 
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differences. The study presented in Section I of the 
dissertation shows that dianide and t-butyl hydroperoxide can 
have markedly differing effects on both protein S-thiolation 
and cell physiology [120]. Many studies of oxidative stress 
in response to diamide and t-butyl hydroperoxide have not 
been included in this discussion either because the 
methodology used is questionable or because the system used 
is not closely relevant to heart. In addition, a great deal 
of the literature on oxidative stress deals with effects 
which are probably not mediated by S-thiolation, such as 
lipid peroxidation, changes in calcium homeostasis and 
increased sensitivity to a variety of toxins. These studies 
have been omitted because they do not add to an understanding 
of the role of S-thiolation in metabolic regulation. 
The study presented in Section II develops several new 
assay methods for determination of S-thiolation of a specific 
protein, creatine kinase. The possibility of a more general 
use of these methods for other S-thiolated proteins is 
discussed. In addition, substantial data on the S-thiolation 
of creatine kinase is presented. S-Thiolation of this enzyme 
during oxidative stress has not been extensively studied, so 
the present work explores a new aspect of metabolic 
regulation in S-thiolation. 
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Explanation of Dissertation Format 
This dissertation follows an alternate format. Two 
Sections comprise the main portion of the dissertation. 
These two sections are research papers which either have been 
published or have been submitted for publication. An 
appendix contains additional material which have not been 
published elsewhere. 
All experiments except the heart cell beating study in 
Figure I-l were performed by the author with the helpful 
advice and discussion of Dr. James A. Thomas. The experiment 
in Figure I-l was performed by Daniel Beidler with direct 
consultation and assistance of the author. All other work 
presented in this dissertation was performed by the author. 
Both manuscripts were prepared by the author, with with the 
helpful advice and discussion of Dr. James A. Thomas. The 
paper from Section I was published in Biochimica et 
Biophysica Acta, Volume 885 (1986), pages 58-67. The 
manuscript from Section II has been submitted to Biochimica 
at Biophysica Acta for publication. 
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SECTION I: A COMPARISON OF PROTEIN S-THIOLATION (PROTEIN 
MIXED-DISULFIDE FORMATION) IN HEART CELLS TREATED 
WITH t-BUTYL HYDROPEROXIDE OR DIAMIDE. 
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Introduction 
Recently, it was demonstrated in this laboratory C13 
that protein S-thiolation (formation of mixed-disulfides 
between low molecular mass thiols such as glutathione and 
protein eulfhydryl groups) occurs under conditions in which 
glutathione becomes oxidized in cultured heart cells. In 
vivo, such conditions might be expected to occur in heart 
tissue in response to the production of activated oxygen 
species such as hydrogen peroxide, superoxide anion, and 
hydroxyl radical. It has been reported that cardiac damage 
during reperfusion following ischemia 112-43 and during 
inflammatory responses [5,6] is related to the production of 
these reduced oxygen species. It has also been suggested 
that xenobiotics such as adriamycin may produce reduced 
oxygen species in cardiac tissue 171. These results suggest 
that protein S-thiolation in cardiac tissue may be an 
important cellular response in several different 
physiological states of oxidative stress. 
Agents which promote oxidation of glutathione have been 
used to study effects of oxidative stress including protein 
S-thiolation. The basic premise in these studies is that 
oxidized glutathione is a direct result of peroxide 
production and that it serves as a direct precursor of 
S-thiolated proteins. This fact remains unproven. Two of 
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the agents most commonly used to study oxidative stress are 
t-butyl hydroperoxide and diamide. The two compounds oxidize 
cellular glutathione [8-13], promote GSSG release from 
cells [9,11,12,14], cause formation of S-thiolated 
proteins [8,10,15,16] and lipid peroxidation [9,17]. The 
effects of t-butyl hydroperoxide are thought to result from 
the action of glutathione peroxidase on t-butyl 
hydroperoxide, resulting in increased production of 
GSSG [12]. Diamide reacts non-enzymatically with sulfhydryl 
groups to oxidize glutathione and other thiols to disulfides 
[13]. Oxidative effects of these two compounds cause 
changes in cellular metabolism which have been attributed to 
S-thiolation of proteins. It has been suggested that protein 
S-thiolation inhibits glycolysis and glycogen synthesis, 
activates glycogenolysis and glucogenesis and increases flux 
through the pentose phosphate pathway [8,9,18-21]. 
The current study was initiated to compare the effects 
of t-butyl hydroperoxide and diamide on cell beating, 
oxidation of glutathione, and S-thiolation of soluble 
proteins in cultured heart cells. The data reported here 
shows that these two reagents had different effects on both 
cell beating and S-thiolation of soluble proteins under 
conditions that produced similar amounts of GSSG in the 
cells. 
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Materials and Methods 
Materials 
Pregnant Sprague-Dawley rats were obtained from Hilltop 
Lab Animals, Scottsdale, PA, USA. Streptomycin 
sulfate-penicillin mixture, fetal bovine serum, and horse 
serum were from H.A.Bioproducts, Walkersville, MD, USA. 
L-35s-cystine was from New England Nuclear, Boston, MA, USA. 
Diamide, t-butyl hydroperoxide, N-ethyl maleimide, iodoacetic 
acid, and 1-fluoro-2,4-dinitrobenzene were from Sigma 
Chemical Company, St. Louis, MO, USA. CMRL-1415 medium [22] 
modified to contain 0.05 mM taurine and one tenth the 
concentration of cysteine and cystine of the original 
formulation was prepared from reagent grade materials. The 
medium also contained 100 jig/ml streptomycin sulfate, 
100 U/ml penicillin, and, where indicated, 5% fetal calf 
serum and 5% horse serum. On storage at 40C,all cysteine in 
the medium was oxidized within 24 h. Therefore specific 
activity of medium cystine was calculated assuming only 
cystine was present in the growth medium. 
Cell Culture 
Besting rat heart cell cultures were prepared from 
2-day-old Sprague-Dawley rats as described by Harary et 
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al. [23] and were maintained on CHHL-1415 medium. Cells were 
plated at 3.6 x 10^ cells per 35 mm culture dish in 2 ml 
serum-containing medium. After one day, medium was removed 
and replaced with fresh serum-containing medium. Two days 
later, medium was removed and replaced with serum-free 
medium. Cells were used for experiments on the fourth day 
after plating. 
Glutathione Analysis 
Glutathione was analyzed by a modification of the method 
of Reed et al. C24]. Medium was rapidly removed from cell 
cultures and residual medium was removed by rapid washing 
with ice cold medium followed by ice cold phosphate-buffered 
saline CNaCl, 8 gm/1; KCl, 0.2 gm/1; Na2HP04, 1.5 gm/1; 
KH2PO4, 0.2 gm/1; pH 7.2). For total glutathione analysis, 
100 ^  5% HCIO4 was added to the washed cells and the 
cultures were set aside for approximately 10 min. The acid 
extract was removed from cells and one tenth volume of 
240 mg/ml iodoacetic acid was added to each sample. Solid 
KHCO3 was added in small increments until CO2 was no longer 
evolved. The reaction was incubated 15 min in the dark to 
allow complete reaction of the iodoacetic acid, and an equal 
volume of 3% 1-fluoro-2,4-dinitrobenzene in absolute ethanol 
was added. All samples were placed in the dark at 40C for at 
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least 24 h and solide were removed by filtration before 
analysis. Glutathione and GSSG were separated by HPLC on an 
AminoPro column (Custom LC, Dallas, Texas) as described by 
Reed et al.£243 and the amount of GSH and GSSG was determined 
by comparison to standard curves prepared from reagent grade 
GSH and GSSG using identical derivatization procedures. 
In order to analyze GSSG in heart cells, two additional 
modifications of the procedure were necessary. Since heart 
cell cultures normally contained too little GSSG to be 
detected by absorbance of the dinitrophenyl derivatives, a 
radioactive detection method was used for GSSG. Cells were 
incubated for 24 h in serum-free medium containing 85 jtM 
L-35s-cystine at 3 x 10® dpm/^mol. After 24 hours, the 
specific activity of glutathione was high enough to detect as 
little as 10 pmol of GSSG. The GSSG from heart cell cultures 
normally contained more than lo3 cpm by this procedure. A 
second modification was required to prevent oxidation of GSH 
during sample preparation. An effective procedure for 
blocking GSH oxidation is to odd N-ethyl maleimide to 
solutions used for extraction of cells [25]. One hundred 
microliters of 5% HCIO4 containing 50 mM N-ethyl maleimide 
was used for cell extraction and the extract was analyzed as 
described for total glutathione. Fractions of the HPLC 
column effluent were collected in liquid scintillation vials. 
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fluor was added and radioactivity was determined. All 
fractions in the radioactive peak with the same retention 
time as GSSG were summed. Since GSSG and GSH should have the 
same specific activity in these cultures, total GSSG was 
calculated from the specific activity of GSH determined in a 
duplicate culture which was not treated with N-ethyl 
maleimide. GSH specific activity varied less than 3% in 
duplicate cultures. Glutathione content of heart cell 
cultures was normalized for variations between cultures by 
determination of the protein content of each culture. The 
cell culture residue remaining after acid extraction was 
solublized with 1.0 M NaOH and protein was assayed as 
described by Lowry et al. [26]. 
Analysis of Protein S-Thiolation 
Protein S-thiolation was analyzed by the 
gel-electrophoresis method previously described El]. The 
procedures for labeling cultures with 35s-cystine were 
modified as follows. First, 50 jig/ml cycloheximide was added 
to the cell cultures to inhibit protein synthesis. Medium 
was removed from cells 30 min later, and serum-free medium 
containing 50 pg/ml cycloheximide and 10 /iM L-35s-cystine at 
3 X lOlO dpm/jimol was placed on the cells. Cultures were 
incubated 4 h with 35S-cystine before beginning experiments. 
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Experiments were terminated by aspirating medium, rinsing the 
cultures twice with ice-cold medium and twice with ice-cold 
phosphate-buffered saline. The entire rinsing procedure 
required less than 15 seconds. Cultures were extracted and 
prepared for electrophoretic analysis as previously described 
C13. In this procedure, N-ethyl maleimide was present during 
extraction of proteins to prevent artifactual S-thiolation. 
The method for SDS-polyacrylamide gel electrophoresis was 
described by Laemmli [27]. 
Results 
Effects of t-Butyl Hydroperoxide and Diamide on the Oxidation 
State of Glutathione 
Heart cells normally contained 11 to 14 nmoles 
glutathione per milligram protein. This is similar to the 
amount in adult rat heart tissue [11,28]. The GSSG content 
of untreated beating heart cells was low and GSH to GSSG 
ratios were between 100 and 200. Thus, cultured heart cells 
were slightly more reduced than heart tissue, in which the 
GSH to GSSG ratio has been reported as 80 to 120 [11,283. 
t-Butyl hydroperoxide and diamide both increased GSSG in 
heart cell cultures and decreased the GSH to GSSG ratios. 
Table I-l shows the effects of 0.2 mM t-butyl hydroperoxide 
on heart cell glutathione. In Experiment 1, GSSG increased 
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Table I-l. Effects of t-butyi hydroperoxide on GSH and GSSG 
in heart cell cultures. Heart cell cultures were 
treated with 0.2 mM t-butyl hydroperoxide for the 
indicated times. Cells were extracted and 
glutathione was analyzed. Data are means ± 
standard deviations from triplicate 
determinations 
Glutathione Content: (nmol/mg protein? 
Time After Total GSSG GSH* GSH/GSSG 
Addition 
Experiment 1 
0 min 11.2±0.5 
1 min 10.4^.2 
3 min 10.6d0.6 
15 min 11.0±0.6 
Experiment 2 
0 rain 13.4±1.7 
3 min 13.3i2.4 
7 min 13.2±1.9 
15 min 12.4±1.5 
0.064±0.Û09 
1.59 ±0.07 
1.57 ±0.07 
0.71 ±0.01 
0.074±0.004 
2.6 ±0.4 
2.2 ±0.3 
1.8 ±0.1 
11.1±0.5 
7.2±2.2 
7.5±0.6 
9.6±0.6 
11-9±1.7 
8.0±2.4 
8.8±1.9 
8.7±1.5 
173±25 
4.5±1.4 
4.8±0.5 
15.5±1.0 
161±24 
3.0±1.0 
3.9±1.0 
4.5±0.9 
^Calculated: GSH = Total glutathione - 2 X [GSSG]. 
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25-fold within one min, and slowly decreased over 15 min to a 
concentration that was still at least lO-fold higher than in 
untreated cells. In Experiment 2, GSSG increased 35-fold 
within 3 min, and slowly decreased over 15 min to a 
concentration that was still 25-fold higher than in untreated 
cells. These results indicate that the effect of t-butyl 
hydroperoxide on glutathione oxidation can be variable, since 
the concentration of GSSG produced in the second experiment 
is 60% greater that that produced in the first. Also, after 
t-butyl hydroperoxide treatment GSSG in the cells decreased 
slowly, and remained elevated 15 minutes after treatment. 
Although extensive oxidation occurred, glutathione was never 
completely oxidized and the cells always contained at least 3 
times as much GSH as GSSG. There was very little loss of 
glutathione from these cells in either experiment. 
Table 1-2 shows that diamide also oxidized GSH rapidly. 
With 0.5 mil diamide, GSSG was highest at 1 min and then 
decreased rapidly. There was a substantial loss of 
glutathione from the cells. With 0.2 mM diamide, substantial 
oxidation of GSH occurred and the loss of glutathione was not 
observed. By 15 min after diamide treatment, the GSSG 
content of these cells was much lower than the GSSG content 
of cells treated with 0.2 mM t-butyl hydroperoxide, even 
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Table 1-2. Effects of diamlde on GSH and GSSG in heart cell 
cultures. Heart cell cultures were treated with 
either 0.2 mM or 0.5 mM diamide as described for 
t-Butyl hydroperoxide. Data are means ± standard 
deviations from triplicate determinations 
Glutathione Content; (nmol/mq protein) 
Time After Total GSSG GSH« GSH/GSSG 
Addition 
Experiment 1. 0.5 mM Diamide 
0 min 
1 min 
3 min 
10 min 
12.2±0.9 0.10±0.02 
10.3±0.4 2.2 ±0.2 
5.2±0.2 1.3 ±0.3 
3.0±1.5 0.30±0.08 
Experiment 2. 0.2 mM diamide 
O min 13.4±1.7 0.074dfc0.004 
3 min 10.6±3.7 1.7 ±0.4 
15 min 14.0±2.0 0.14±0.04 
12.0±0.9 
5.8±0.5 
2.5±0.5 
2.4±1.5 
11.9±1.7 
7.2±3.7 
13.7±2.0 
120±26 
2.6±0.3 
1.9±0.6 
7.9±5.6 
161±24 
4.3±2.4 
101±33 
^Calculated: GSH = Total glutathione - 2 X CGSSG]. 
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though the GSSG content of the cells was similar at earlier 
times. 
The experiment represented in Table 1-3 was designed to 
determine the concentration of diamide that would produce an 
equivalent oxidation of glutathione as did 0.2 mM t-butyl 
hydroperoxide. Cultures were treated for 3 min with each 
compound. Diamide did not produce as much GSSG as t-butyl 
hydroperoxide at any concentration because the loss of 
glutathione from diamide-treated cells was much greater than 
from t-butyl hydroperoxide-treated cells. The ratio of GSH 
to GSSG with 0.2 or 0.5 mM diamide was equal to or less than 
that with 0.2 mM t-butyl hydroperoxide indicating that the 
redox state of the glutathione in the cells was similar. 
This experiment shows that each agent causes a general 
increase in oxidized glutathione, but the oxidation state of 
the cells may vary due to losses in the total glutathione 
pool. As a result, it was not possible to produce cells with 
an identical oxidation state of glutathione following 
treatment with the two compounds. 
Loss of glutathione from cells was often observed 
following treatment with either t-butyl hydroperoxide or 
diamide. In some experiments, the losses were large, i.e. 
Experiment 1 of Table 1-2. In other experiments, losses were 
not apparent, i.e. Table I-l and Experiment 2 of Table 1-2. 
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Table 1-3. Concentration dependence of diamide and t-butyl 
hydroperoxide effects on GSH and .GSSG in heart 
cell cultures. Cell cultures were treated three 
min with the indicated concentrations of t-butyl 
hydroperoxide or diamide. Data are means ± 
ranges from duplicate determinations 
Glutathione Content: (nmol/mg protein) 
Time After Total GSSG GSH* GSH/GSSG 
Addition 
Experiment 1 
No Addition 16.3±3.0 0.15±0.09 16.0±3.0 
0.2 mM tBuOOH 12.7±0.5 3.21±0.18 6.28±0.5S 
0.5 mM Diamide 6.5±1.5 2.01±0.72 2.47dbl.80 
0.2 mM Diamide 7.5±0.5 1.96±0.42 3.51±0.79 
0.1 mM Diamide 11.7±0.6 0.59±0.05 10.6±0.6 
0.05 mM Diamide 14.1±0.5 0.46±0.09 13.2±0.5 
108±47 
2.0±0.2 
1.2±1.0 
1 .8±0.6  
18 ± 2 
29 ± 6 
^Calculated: GSH = Total glutathione - 2 X [GSSG]. 
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All cells from a single experiment either lost glutathione 
with both agents or did not lose it with either agent. When 
loss of glutathione did occur, diamide always caused more 
extensive loss of glutathione than did an equivalent 
concentration of t-butyl hydroperoxide. A specific export of 
GSSG from heart has been proposed [12] which requires a 
carrier protein. Perhaps in neonatal heart cultures, 
expression of this protein varies between preparations. 
The experiments represented in Tables I-l to 1-3 
illustrate three principles of cardiac cell glutathione 
metabolism. First, both diamide and t-butyl hydroperoxide 
caused extensive oxidation of heart cell glutathione. 
Second, cells lost substantial amounts of glutathione on 
occasion. In general, loss of glutathione could occur with 
either compound, but losses following diamide treatment were 
usually greater. Third, the oxidation state of glutathione 
in heart cells treated with an oxidizing agent may vary 
between cell preparations. These facts suggest that it is 
always important to analyze the glutathione content and its 
state of oxidation in experiments that tested the effects of 
these compounds on specific protein S-thiolation. 
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Effects of t-Butvl Hydroperoxide and Diawide on Beating of 
Heart Cells 
Both t-butyl hydroperoxide and diamide had effects on 
cell beating (Figure I-l). No effects of t-butyl 
hydroperoxide were observed at 0.05 mM or lower. At 0.2 mM 
t-butyl hydroperoxide, beating slowed gradually over about 25 
min and eventually stopped. Once beating stopped, the cells 
did not begin beating again, even after long periods of time 
(24 h). If medium was changed after approximately 30 min, 
beating returned to normal and cultures observed 24 h later 
appeared normal. In contrast to t-butyl hydroperoxide, 
diamide had a major effect on cell beating. Above 0.1 mM, 
diamide quickly stopped cell beating. Cultures resumed a 
normal or elevated beating rate after 15-45 min. Cells 
observed 24 h after diamide treatment appeared normal. 
Diamide had no major long-term toxic effect on the cells, 
even though beating ceased rapidly upon diamide addition. 
t-Butyl hydroperoxide was more toxic even though beating 
ceased only after 20 min. The rapid effect of diamide on 
cell beating implies some specific mechanism for stopping 
contraction without causing major damage to the cell. Thus, 
the two compounds had very different effects on beating of 
Figure 1-1. The effect of t-butyl hydroperoxide and diamide on beating o.f heart 
cell cultures. Heart cell cultures were treoted with the indicated 
concentrations of t-butyl hydroperoxide or diamide by addition of 
20 jil of a lOOx stock to the 2 ml medium on the culture plate. 
Open and closed circles ore duplicate cultures with identical 
treatments. The closed squares in the 0.05 mH t-butyl 
hydroperoxide figure are the beating rotes of untreated cells 
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cultured heart cells even though both produced a the expected 
rapid oxidation of glutathione. 
Effects of t-Butvl Hydroperoxide and Diaraide on Protein 
S-Thiolation 
Figure 1-2 shows the effect of 0.2 mM t-butyl 
hydroperoxide on protein S-thiolation in heart cells. 
t-Butyl hydroperoxide caused a transient increase in 
S-thiolation in a distinct group of soluble proteins. 
Extensive S-thiolation occurred by one minute after t-butyl 
hydroperoxide treatment, with the maximum effect at 3-7 min. 
By 15 min S-thiolation had begun to decrease. A variety of 
proteins were S-thiolated, but a prominent radioactive band 
with an apparent molecular mass of about 23 kDa was the 
single most highly S-thiolated protein. The oxidation state 
of glutathione in these cells was shown Table I-l. GSSG 
reached a maximum by 1 minute, remained elevated for 
3 min and then decreased slowly. S-Thiolation of proteins 
did not reach a maximum until 3 min, and this maximum was 
maintained for 7 min. Therefore, S-thiolation of proteins 
occurred slightly later than oxidation of glutathione. 
Figure 1-3 shows the effect of 0.2 mM diamide on protein 
S-thiolation. Diamide caused more extensive protein 
S-thiolation than t-butyl hydroperoxide and different 
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Figure 1-2. The effect of t-butyl hydroperoxide on protein S-thloletlon. 
Heart cell cultures were labeled with L-35s-oy#tine in the presence 
of cycloheximide. Radioactive cultures were treated with 
0.2 wM t-butyl hydroperoxide for the times indicated. Cells were 
extracted and proteins were separated by electrophoresis on 
8K acrylamide gels as described in Materials and Methods 
Figure 1-3. The effect of dlomide on protein S-thiolotion. Radioactive heart 
cell culture* were treated with 0.2 mM diamide for the time# 
indicated. Cell* were extracted and protein* were separated by 
electrophoresis on 7% ocrylomide gels as described in Materials and 
Methods 
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proteins became S-thiolated with the two agents. In addition 
to the 23 kDa protein, which was highly S-thiolated by 
t-butyl hydroperoxide, proteins at 42 kDa and 97 kDa and 
three proteins around 35 kDa were all highly S-thiolated by 
diamide. Many other proteins were also S-thiolated to a 
lesser extent. The glutathione analyses for these cells was 
presented in Experiment 2 of Table 1-2. The decrease in 
total glutathione 3 min after diamide treatment could be due 
to the formation of large amounts of S-thiolated proteins, 
since the total glutathione at 15 min was the same as in 
untreated cells. Though the GSSG content of the 
diaiRide-treated cells was about the same as the GSSG content 
of the cells treated with 0.2 mM t-butyl hydroperoxide 
(Figure 1-2), much more S-thiolation occurred in response to 
diamide than after treatment with t-butyl hydroperoxide. In 
addition, though GSSG returned to near normal by 15 min, 
S-thiolation of several proteins persisted. This was 
especially true of the highly S-thiolated protein with an 
apparent molecular mass of 42 kDa. This may suggest a 
specific effect of diamide on protein S-thiolation. 
Since diamide caused a different specificity of 
S-thiolation as well as more extensive S-thiolation than did 
t-butyl hydroperoxide, the compounds were compared directly 
in an experiment on a single group of heart cells. Figure 
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1-4 shows the comparison o£ protein S-thiolation with 0.2 mM 
t-butyl hydroperoxide and with several concentrations of 
diamide. Under conditions that produced approximately equal 
S-thiolation of proteins, i.e., 0.2 mM t-butyl hydroperoxide 
and 0.1 mM diamide, the specificity of protein modification 
with diamide was markedly different from that with t-butyl 
hydroperoxide. The glutathione analyses of these cells was 
shown in Table 1-3. Under conditions where the GSH to GSSG 
ratio was equivalent after 3 min, i.e., 0.2 mM t-butyl 
hydroperoxide and 0.2 mM diamide, the specificity of 
S-thiolation was different with the two agents and 
S-thiolation was significantly greater with diamide than with 
t-butyl hydroperoxide. 
The extent of S-thiolation in three of the most heavily 
S-thiolated proteins from Figure 1-4 was estimated from 
densitometric scans of the autoradiogram and the 
protein-stained gel. Standards were used to determine the 
amount of protein and radioactivity in each band. The 
estimates of radioactivity assume that only 35s-glutathione 
and not some other 35s-labelled thiol was bound to the 
proteins. It is possible that other thiols also participate 
in S-thiolation of proteins. The specific activity of the 
35s-giutathione was determined from the acid soluble GSH in 
identical cultures. Table 1-4 shows quantitative estimates 
Figure 1-4. Conparieon of the effects of diomide and t butyl hydroperoxide on 
protein S-thiolotion. Radioactive heart cell cultures were treated 
for 3 «in with 0.2 mM t butyl hydroperoxide or with the indicated 
concentration of diamide. Cells were extracted and proteins were 
separated by electrophoresis on dK acrylanide gels as described in 
Materials and Methods 
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Table 1-4. The effect of diamide and t-butyl hydroperoxide 
on protein S-thiolation in heart cells. Data on 
S-thiolation in three proteins from Figure 4 were 
estimated as described in the text 
Treatment Protein Band (glutathione 
residues per subunit) 
23 kDa 42 kDa 97 kDa 
0.2 mM tBuOOH 0.2 0.03 0.09 
0.5 mM Diamide 0.6 0.5 0.6 
0.2 mM Diamide 0.5 0.4 0.6 
0.1 mM Diamide 0.2 0.1 0.2 
0.05 mM Diamide 0.05 0.07 0.05 
No Addition 0.006 N.D.a 0.02 
®Not detected. 
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of the S-thiolation of three proteins with apparent molecular 
mass of 2.3, 42, and 97 kDa. Only the 23 kDa protein was 
extensively S-thiolated by t-butyl hydroperoxide, while all 3 
of the proteins were extensively S-thiolated by diamide. The 
maximum S-thiolation observed was 0.6 mol/mol protein. The 
23 kDa and the 97 kDa proteins both reached that extent of 
S-thiolation. The concentration-dependence of S-thiolation 
by diamide was similar for each of these three proteins. 
Discussion 
This study shows that S-thiolation of proteins occurs in 
response to two compounds that oxidize glutathione in heart 
cells. Exchange between soluble glutathione and protein 
sulfhydryls by a thiol-disulfide reaction: 
PSH + GSSG > PSSG + GSH 
is a possible mechanism for both formation and breakdown of 
S-thiolated proteins in vivo. This reaction is probably 
catalyzed by one or more enzymes in.vivo. An enzyme that 
catalyzes dethiolation of proteins by this reaction has been 
isolated [29]. This enzyme shows a broad specificity for low 
molecular weight thiols [30]. It has not been successfully 
used to catalyze S-thiolation of proteins. 
A number of proteins became S-thiolated in our study, 
but all of the proteins were not equally S-thiolated. Some 
of the specificity of S-thiolation may be due to differences 
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in the reaction rate of protein sulfhydryls with differing pK 
values. The RS~ form of the sulfhydryl probably reacts much 
faster than the uncharged RSH form [19,31,32]. This 
mechanism cannot account for the difference in specificity 
observed with diamide and t-butyl hydroperoxide in this 
study, since the amount of GSSG in the cells was similar with 
both agents, while diamide caused more extensive protein 
S-thiolation with a different specificity. Enzyme catalysis 
of S-thiolation could account for these differences, but no 
enzyme has been shown to catalyze S-thiolation to date. It 
will be important to determine if such enzymes exist. A 
second reason for the different patterns of S-thiolation may 
reside in the mechanism of the two agents. Diamide can 
probably react directly with protein sulfhydryls to form 
mixed disulfides or protein-protein disulfides without the 
participation of GSSG in the reaction. By this mechanism, an 
activated protein sulfhydryl is produced by reaction with 
diamide and this intermediate reacts directly with GSH or a 
protein sulfhydryl. A third consideration for the different 
effects might be related to membrane receptor function. 
t-Butyl hydroperoxide produces protein S-thiolation by 
increasing the GSSG concentration inside the cell. Diamide 
can react with sulfhydryls on the outer surface of the cell 
as well as those inside. Diamide might cause S-thiolation or 
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oxidation of a sulfhydryl in a specific membrane protein. 
This change in the membrane protein could then stimulate 
S-thiolation of selected cellular proteins. This possibility 
is suggested by studies in which thiol-disulfide changes in 
receptors have been implicated in the action of 
insulin [33-35], opiates C363, and in the release of 
acetylcholine [37] and other neurotransmitters [383. The 
importance of changes in membrane sulfhydryls in regulation 
of S-thiolation could be tested in the future with impermeant 
oxidizing agents. 
The regulation of beating in heart cells is a complex 
phenomena. Since activated oxygen species may be important 
in cardiac damage [2-8], the possible involvement of 
S-thiolation in beating is of interest. The effects of 
t-butyl hydroperoxide on cell beating may not be directly 
related to either oxidation of glutathione or protein 
S-thiolation since the GSSG concentration and protein 
S-thiolation substantially decreased before beating ceased. 
t-Butyl hydroperoxide has been reported to cause lipid 
peroxidation ZZl and membrane damage may be responsible for 
the cessation of beating in these cells. The effects of 
diamide on beating may, however, be directly related to 
S-thiolation of some specific protein since the effects on 
beating and on protein S-thiolation are both rapid and 
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reversible. Though both GSSG and GSH/GSSG returned to near 
normal by 15 min after diamide treatment, S-thiolation of 
several proteins persisted. These proteins are of special 
interest because beating did not return to normal for 30 to 
45 minutes. The 42 kDa protein was highly S-thiolated by 
diamide and only slightly S-thiolated by t-butyl 
hydroperoxide (see Figure 1-4 and Table 1-4). The 
S-thiolation of this protein persisted much longer than most 
other cellular proteins,and the time course of S-thiolation 
of this protein and the cessation of beating were roughly 
correlated. It has been proposed that diamide interferes 
with cell beating through release of mitochondrial calcium 
[39] however the exact mechanism of this release has not been 
elucidated. A possibility suggested by this study is that 
S-thiolation of a specific protein may be responsible for the 
inhibition of cell beating in response to diamide but not 
t-butyl hydroperoxide. 
In conclusion, though both diamide and t-butyl 
hydroperoxide are effective glutathione oxidizing agents, the 
ability of diamide to alter protein S-thiolation to a much 
greater extent makes the effects of the two agents on heart 
cells markedly different. These studies suggest that 
thiol-disulfide exchange is not the only mechanism for 
protein S-thiolation in vivo when cells are treated with 
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these two agents. Additional studies of the enzymology of 
S-thiolation and dethiolation are important to an 
understanding of these processes. Further attempts to 
identify the proteins S-thiolated by diamide will help 
determine the role of S-thiolation in the regulation of cell 
contraction-
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Introduction 
Protein S-thiolation (formation of mixed-disulfides 
between thiols such as glutathione and protein sulfhydryl 
groups) may be an important mechanism for regulation of 
metabolism during oxidative stress in cells. Oxidative 
stress in heart results from reperfusion injury [1-3], 
inflammation C4,53, or chemical toxicity [6]. 
Previous studies in our laboratory have shown that 
S-thiolation of soluble proteins occurs under conditions in 
which glutathione becomes oxidized in cultured heart cells in 
response to diamide [7]. In a subsequent study, diamide 
caused a transient increase in protein S-thiolation C83. 
S-Thiolation of most proteins decreased rapidly after 
S-thiolation, but a protein with a subunit molecular weight 
of 42 kDa remained S-thiolated longer than most other 
proteins. The current paper shows that this 42 kDa protein 
is creatine kinase. 
Creatine kinase is known to contain a reactive 
sulfhydryl which is important for activity. It therefore 
seemed likely that inhibition of creatine kinase would occur 
if the enzyme became S-thiolated, and that inhibition of 
creatine kinase could cause significant changes in heart 
energy metabolism. Creatine kinase has been proposed to be 
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involved in a creatine-creatine phosphate energy shuttle C93 
which moves high energy phosphate from the mitochondria to 
the contractile apparatus of the cell. The current study was 
undertaken to determine if S-thiolation of creatine kinase 
could contribute to the effects of diamide on heart cells. 
Materials and Methods 
Materials 
Neonatal Sprague-Dawley rats were obtained from BioLab, 
Inc., St. Paul, MN, USA. L-35s-cystine was from New England 
Nuclear, Boston, MA, USA. Diamide, taurine, N-ethyl 
maleijnide, iodoacetic acid, iodoacetamide, and bovine serum 
albumin were from Sigma Chemical Company, St. Louis, MO, USA. 
CMRL-1415 medium [10], modified to contain 0.5 mM taurine, 
150 fïn cysteine and 10 ^  cystine, was prepared from reagent 
grade materials. The medium also contained 
100 /ig/ml streptomycin sulfate, 100 U/ml penicillin, and, 
where indicated, 5% fetal calf serum and 5% horse serum. 
Streptomycin sulfate-penicillin mixture, fetal bovine serum, 
and horse serum were from M.A. Bioproducts, Walkersville, MD, 
USA. 
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Cell Culture 
Beating rat heart cell cultures were prepared from 
2-day-old Sprague-Dawley rats as described by Harary et al. 
Cil]. Cells were plated on 35 mm dishes at 4 x 10^ cells per 
dish in 2 ml serum-containing medium. Medium was removed and 
replaced with fresh serum-containing medium one day after 
culturing. Two days later, medium was removed and replaced 
with serum-free medium. Cells were used for experiments on 
the fourth day after plating. 
Creatine Kinase Assays 
Heart tissue was homogenized in 1 volume of buffer <20 
mM HEPES, 5mM EDTA, 5 mM EGTA, pH 7.4) using a Tissumizer 
(Tekmar) for 30 seconds. Heart cell culture extracts were 
prepared by adding 20 jal buffer to each 35 mm culture and 
scraping cells from the plate. All samples were transferred 
to microcentrifuge tubes and centrifuged 5 minutes at 15,000 
X g. The supernatants were removed and diluted 100-fold (for 
heart tissue) or 10-fold (for heart cell cultures) in 50 mM 
HEPES pH 7.4, 1 mg/ml BSA. Small aliquots (10-100 ^ ) of the 
diluted samples were assayed for creatine kinase activity. 
Creatine kinase was assayed at 300C in the direction of 
creatine formation by the method of Cook, Kenyon and Cleland 
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[12] with the following modifications. AMP (3mM) was added 
to the assay mix to inhibit the adenylate kinase activity of 
tissue extracts as suggested by Bittl et al. [133. 
Glucose-6-phosphate dehydrogenase from Leuconostoc 
mesenteroides, which has higher activity with NAD than with 
NADP, was used, and 3 mM NAD was substituted for NADP as 
suggested by Kraaijenhagen et al. [14]. Each 1 ml assay 
contained 75 mM HEPES-KOH, pH 7.4, 1 mg/ml BSA, 5 mM 
Mg<CH3C00~)2» 3 mM ADP, 25 mM Phosphocreatine, 3 mM glucose, 
3 mM NAD, 3 mM AMP, 3 units/ml yeast hexokinase, and 6 
NAD-units/ml Leuconostoc glucose-6-phosphate dehydrogenase. 
Analysis of Protein S-Thiolation 
Protein S-thiolation was analyzed by the 
gel-electrophoresis method previously described [7,8]. 
Briefly, heart cell cultures were incubated with 35-S cystine 
in the presence of cycloheximide to radioactively label the 
glutathione pool of the cells without incorporating 
radioactivity into the proteins. Soluble proteins were 
extracted and prepared for SDS-polyacrylamide gel 
electrophoresis as previously described [73. 
Creatine kinase S-thiolation was analyzed by thin-gel 
isoelectric focusing as previously described [15]. Samples 
were prepared for isoelectric focusing as follows. Heart 
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extract was prepared as described above and S-thiolated by 
incubation with GSSG. lodoacetamide and pH 8 Tris-HCl buffer 
were added to give final concentrations of 50 mM each. 
Samples were incubated 15 minutes at room temperature to 
allow the iodoacetamide to fully react. 
Isoelectric focusing gels were prepared just before use. 
The gels were 4% T-2.6% C acrylamide and contained 3% 
ampholytes (LKB). The ampholyte mixture was 1 volume pH 
3.5-10 ampholytes with 3.6 volumes pH 5-8 ampholytes. Gels 
were poured on GelBond PAG film CFMC Corporation) to 
facilitate handling. Gels were prefocused 10 minutes, 
samples were applied, and gels were focused 65 minutes at 
40c, with limiting values of 1500 V, 44 mA, 1Ô W for a 16 cm 
wide gel. 
Other Assays 
Glutathione was analyzed by a modification of the HPLC 
method of Reed et al. [16] as previously described [8]. 
Protein was determined by the method of Lowry et al. [17]. 
The method of Laemmli [18] was used for SDS- polyacrylamide 
gel electrophoresis. 
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Statistics 
Data from all experiments are means ± standard 
deviations from triplicate determinations unless otherwise 
noted. In figures, omission of error bars from individual 
data points indicates the error in the data is smaller than 
the symbol used to represent the data point. 
Results 
Analysis of Creatine Kinase S-Thiolation 
Recently, our laboratory developed a method for 
determination of S-thiolated proteins by isoelectric focusing 
[15]. In brief, a protein that was S-thiolated by 
glutathione contained an additional negative charge, and 
could be separated from protein which was not S-thiolated by 
isoelectric focusing in a thin polyacrylamide gel. Samples 
were modified with iodoacetamide before focusing to eliminate 
any charge on the free sulfhydryl groups, A sample treated 
with iodoacetic acid was also usually run to determine the 
location of proteins when reactive sulfhydryls were modified 
by a negatively charged group. When bovine heart extracts 
were incubated with G5SG under conditions appropriate for 
S-thiolation of proteins (Figure II-IA) a prominent protein 
Figure III. Reaction of bovine heart extract with GSSG. (A) Freshly prepared 
bovine heart extroot waa incubated for the tlmea indicated in the 
preaence of 50 mil GSSG. The reaction waa terminated by addition 
of lodoocetamide and pH 8 Tria buffer at a final concentration of 
SO mil each. Sanplea were applied to a pH 5-8 laoelectric focuaing 
gel and focused 65 minutea. The lane labeled lAA ia bovine heart 
extract treated with iodoacetio acid. <B) Data fro* part A 
quantitoted by donaitometry 
o 1 2 4 8 16 32 lAA 
Minutes with 50 mM GSSG 
B 
40 
30 
Ù 
O 
# 
10 20 
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with a pi of 5.4 gave rise to two protein bands with pi's of 
6.3 and 6.2. If the pi 6.3 and 6.2 bands were cut from the 
gel, reduced with DTT, and treated with iodoacetamide, they 
focused at pi 6.4, showing they were reduction-sensitive 
forms of the pi 6.4 protein. The pi 6.4 protein was 
unchanged by the same treatment. When bovine extract was 
treated with iodoacetic acid (right lane. Figure II-IA) the 
pi 6.4 band disappeared and a pi 6.2 band appeared. Thus, it 
appeared that the pi 6.3 and 6.2 bands were the result of 
S-thiolation of a protein with two reactive sulfhydryl 
groups. The pi 6.4 protein band was eluted from the gel and 
subjected to SDS-polyacrylamide gel electrophoresis. It had 
an apparent subunit molecular weight of 42 kDa. 
Our previous studies with neonatal heart cells in 
culture discovered a prominent 42 kDa protein which became 
S-thiolated in response to both diamide and t-butyl 
hydroperoxide [7,8]. Since this protein was present in high 
concentration and was S-thiolated under a variety of 
conditions, it was suspected that the 42 kDa protein from 
bovine heart and heart cells might be the same. Since 
creatine kinase is present in high concentration in heart and 
is a dimer of 42 kDa subunits, purified bovine heart creatine 
kinase was compared with bovine heart extracts by isoelectric 
focusing. The commercial enzyme focused at the same location 
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as the pi 6.4 bovine heart protein and gave rise to two 
S-thiolated bands on incubation with GSSG which focused at 
locations identical to the S-thiolated bands from bovine 
heart extract. To confirm that the bands from S-thiolated 
bovine heart extract were creatine kinase, the bands with 
pi's of 6.2, 6.3, and 6.4 were cut from the gel, extracted 
into buffer containing DTT, and creatine kinase activity was 
determined. Activity could be recovered from these bands 
because gels were run under non-denaturing conditions and the 
S-thiolated sulfhydryl groups were protected from reaction 
with iodoacetamide. Thus, reduction with DTT should 
reactivate the S-thiolated enzyme forms but not the enzyme 
which was not S-thiolated. By this procedure, the gel bands 
with pi's of 6.2 and 6.3 were shown to contain S-thiolated 
creatine kinase, but no activity was recovered from the band 
with a pi of 6.4. We therefore concluded the pi 6.4 protein 
from bovine heart extracts was creatine kinase which was not 
S-thiolated, the pi 6.3 protein was creatine kinase 
S-thiolated on one sulfhydryl, and the pi 6.2 protein was 
creatine kinase with two S-thiolated sulfhydryls. Since the 
active form of creatine kinase is a dimer and each subunit 
contains a single reactive sulfhydryl [19], it is likely that 
the pi 6.3 band has one S-thiolated subunit and the pi 6.2 
band has two S-thiolated subunits. 
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Analysis of the gel in Figure II-l by scanning 
densitometry allowed quantitation of the S-thiolation state 
of the creatine kinase. The percent S-thiolation of the 
protein was determined by adding the area of the pi 6.2 band 
(2 glutathione residues per dimer) plus one half the area of 
the pi 6.3 band (1 glutathione residue per dimer), and 
dividing by the total area of all three bands. The time 
course of S-thiolation in this experiment is shown in 
Figure II-IB. 
Since S-thiolation of creatine kinase in rat heart and 
neonatal rat heart cell cultures was of greater experimental 
interest than bovine heart, studies were undertaken to 
determine if the isoelectric focusing method was suitable for 
determination of creatine kinase S-thiolation in rat heart. 
To determine which bands from isoelectric focusing gels were 
creatine kinase, rat heart extracts were S-thiolated by 
incubation with GSSG, and the molecular weights of gel bands 
and creatine kinase activity of S-thiolated bands were 
determined as described for bovine heart. The isoelectric 
focusing analysis of rat heart extracts is compared to bovine 
heart in Figure II-2. In rat heart extracts, creatine kinase 
focused at a more acidic pH than in bovine heart. The fully 
reduced form of rat heart creatine kinase focused at a pH of 
6.2, while the S-thiolated forms with one and two glutathione 
Bovine Hear# 
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Figure II-2. Comparison of bovine and rat, heart proteins separated on 
Isoelectric focusing gels. Extracts from bovine and rat heart 
were prepared and treated as described In "Materials and Methods." 
lAm, heart extract treated with lodoacetamlde. lAA, heart extract 
treated with iodoacetic acid. S-Thiolated, heart extract 
S-thiolated with glutathione by Incubation 30 minutes at pH 8 with 
50 mM GSSG, followed by treatment with lodoacetamlde. Samples 
were focused 65 minutes on a pH 5-8 isoelectric focusing gel 
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residues per dimer had pi's of about 6.1 and 6.0 
respectively. In addition to creatine kinase, a major 
protein <16 kDa) which may also become S-thiolated occurred 
in this area of the gel. The reduced form of this protein 
coincided with the location of creatine kinase S-thiolated by 
one glutathione per subunit (compare the pi 6.1 band in the 
S-thiolated lane with the 16 kDa protein band in the 
iodoacetamide treated lane). In S-thiolated samples, the 16 
kDa protein band could not always be resolved from the 
creatine kinase band. As a result, determination of the 
S-thiolation of creatine kinase by isoelectric focusing was 
not a simple procedure in rat heart extracts. 
Two-dimensional gels or an antibody staining procedure 
specific for creatine kinase would make it possible to 
quantitate the creatine kinase band in spite of the 
interfering protein. We instead developed a simpler method 
based on enzyme activity, which did not utilize isoelectric 
focusing. 
The activity assay for determination of creatine kinase 
S-thiolation was based on the fact that either S-thiolation 
by glutathione or reaction with N-ethylmaleimide (NEM) 
completely inactivates this enzyme [19]. Both compounds 
react with the same sulfhydryl group. Therefore, if tissue 
extracts are prepared in the presence of NEM, all free 
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sulfhydryl groups on creatine kinase would rapidly react and 
inactivate the enzyme. Sulfhydryl groups which were 
S-thiolated before tissue disruption would be protected from 
reaction with NEM. Reduction of the extract with 
dithiothreitol (DTT) would regenerate reduced sulfhydryl 
groups from S-thiolated sulfhydryls but not from those 
modified by NEM. Creatine kinase activity, assayed in a 
sample treated with NEM and subsequently reduced with DTT, 
should be a direct measure of the amount of S-thiolated 
creatine kinase in the original sample. This procedure will 
be referred to as an "activity assay" for creatine kinase 
S-thiolation. 
NEM was necessary during tissue extraction because, in 
the presence of oxygen and transition metals such as Fe+++, 
glutathione and other thiols can spontaneously oxidize. 
Exchange between oxidized glutathione (GSSG) and proteins can 
lead to S-thiolation. NEM reacts rapidly at neutral pH to 
block free sulfhydryls, preventing this artifactual 
S-thiolation. 
For the creatine kinase activity assay, two samples were 
required for quantifying protein S-thiolation. To determine 
total creatine kinase activity, a sample was extracted in 20 
mM HEPES, 5 mM EDTA, 5 mM EGTA, pH 7.4. To determine 
S-thiolated creatine kinase, a second sample was extracted in 
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the same buffer containing 50 mM NEM. The NEM was allowed to 
react 15 minutes at room temperature before samples were 
diluted at least 10-fold in 50 mM HEPES, 1 mg/ml BSA, 20 mM 
DTT, pH 7.4. After a 15 minute incubation at room 
temperature, samples were stored on ice for assay. 
The activity assay method was tested with bovine heart 
creatine kinase since it was readily available in a pure form 
that could be analyzed quantitatively by isoelectric 
focusing. The enzyme was 5-thiolated by incubation for 30 
minutes with 50 mM GSSG at pH 8. Excess GSSG was removed by 
extensive dialysis, and the enzyme was assayed. The results 
of these assays are shown in part A of Table II-l. The 
activity of the S-thiolated enzyme was determined before and 
after reduction with DTT, and the activity before reduction 
was subtracted from the activity after reduction to determine 
the "loss of activity on S-thiolation." The enzyme lost 
about 64% of its activity upon S-thiolation. The same enzyme 
preparation was assayed by the "activity assay" for 
S-thiolation and the resulting activity is shown in the 
column labeled "activity assay." The activity in this assay 
was equal to the activity lost upon S-thiolation. The 
S-thiolation state of this purified enzyme was also 
determined by reducing the enzyme with 20 mM DTT and 
quantitating the amount of GSH released by HPLC. This 
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Table II-l. Activity assay for S-thiolation of heart creatine 
kinase. Purified bovine heart creatine kinase 
and extracts of either rat heart or neonatal rat 
heart cell cultures were incubated 30 minutes 
with 50 mM GSSG at pH 3.0 to S-thiolate the 
creatine kinase. Samples were diluted in 50 mM 
HEPES 1 mg/ml BSA, pH 7.4 with (reduced enzyme) 
or without (S-thiolated enzyme) 20 mM DTT. 
ACTIVITY ASSAY- Each S-thiolated sample was 
incubated 15 minutes at room temperature with 
50 mM NEM, and then diluted in 50 mM HEPES 
1 mg/ml BSA, pH 7.4 containing 20 mM DTT. 
Samples were kept 15 minutes at room temperature 
and creatine kinase activity was'assayed 
SOURCE OF • REDUCED S-THIOLATED LOSS OF ACTIVITY 
CREATINE ENZYME ENZYME ACTIVITY ON ASSAY 
KINASE (FULLY ACTIVE) S-THIOLATION® 
units per ml 
A. Purified 222±10 73±3 143±13 151*3 
Bovine Heart 
B. Rat Heart 399±13 100±2 299±15 294±7 
Extract 
C. Neonatal 1.09±0.08 0.54±0.03 0.56±0.09 0.56±0.02 
Heart Cell 
Extract 
®Loss of activity on S-thiolation = reduced enzyme -
S-thiolated enzyme. 
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enzyme, which was 64% inactivated by S-thiolation, contained 
0.64 ± 0.05 GSH per subunit. Thus, with a purified bovine 
heart enzyme, S-thiolation determined by two independent 
methods, loss of activity and quantitation of bound 
glutathione, agrees with S-thiolation determined by the 
"activity assay" indicating the activity assay is a good 
measure of creatine kinase S-thiolation. 
Neither NEM concentration nor length of the NEM 
treatment were critical. Samples could be treated with 2 to 
50 mM NEM or left in the presence of NEM at least 75 minutes 
at room temperature. After reduction with DTT they were 
stable at least three hours on ice. 
The activity assay for S-thiolation was compared to the 
isoelectric focusing method with bovine heart extracts. The 
comparison of S-thiolation determined by the two methods is 
shown in Figure II-3. The results from the two methods were 
identical, suggesting that the activity assay or the 
isoelectric focusing procedure may be used to determine 
protein S-thiolation. The activity assay is a simpler 
procedure, while the isoelectric focusing method permits 
determination of the relative amounts of each molecular 
species present in the sample. 
The experiments in parts B and C of Table II-l show that 
the activity assay for creatine kinase S-thiolation worked 
Figure II-3. A comparison of creatine kinase S-thioiation analyzed by 
isoelectric focusing or by "activity assay." Triangles, 
densitometric analysis of the isoelectric focusing gel fro* Figure 
2. Circles with error bars, data from the activity assay for 
creatine kinase S-thiolation (assay method in text) 
I I 
50 
40-
3 30-
20 
CO 
a. 
30 
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equally well in rat heart tissue extracts and neonatal heart 
cell culture extracts as it did with the purified bovine 
heart enzyme. Extracts from either rat heart tissue or 
neonatal heart cell cultures were incubated 30 min with 50 mM 
GSSG to S-thiolate the creatine kinase, and the activity lost 
upon S-thiolation was comparable to that measured by the 
"activity assay." 
Effects of Diamide on Creatine Kinase S-Thiolation in Heart 
Cell Cultures 
A previous study from our laboratory showed that diamide 
causes a transient increase in S-thiolation of soluble 
proteins and a transient inhibition of cell beating C8]. In 
that study, a major soluble protein with a subunit molecular 
weight of about 42 kDa was highly S-thiolated by treatment 
with diamide, and the 42 kDa protein remained S-thiolated 
longer than other S-thiolated proteins. Since it was 
suspected that this 42 kDa protein was creatine kinase, the 
S-thiolation of the 42 kDa protein was analyzed in relation 
to other heart cell proteins during a period of S-thiolation 
and recovery in cultured heart cells. The cells were 
incubated with 35s-cystine to radioactively label cell 
glutathione, 0.2 mM diamide was added, and S-thiolation of 
soluble proteins was determined by SDS-polyacrylamide gel 
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electrophoresis. The time course of radioactive labeling for 
12 S-thiolated proteins was quantitated by densitometry. 
Figure II-4 shows a plot of relative S-thiolation for 4 of 
these 12 proteins. The 23, 35, and 97 kDa proteins were 
major S-thiolated bands in this analysis and were 
representative of 11 of the 12 proteins. These proteins 
attained their maximum S-thiolation 2 minutes after diamide 
treatment. The 42 kDa protein S-thiolated more slowly than 
the other cellular proteins, and also dethiolated more 
slowly. The GSSG to GSH ratio was also highest at 2 minutes 
in this experiment, as shown in Figure II-4. All proteins 
remained S-thiolated after GSSG / GSH began to decrease, and 
the 42 kDa protein did not reach its maximum S-thiolation 
until after GSSG / GSH had decreased significantly. 
Creatine kinase was the only major 42 kDa protein in 
extracts from adult rat heart. Therefore, the S-thiolation of 
the 42 kDa band in cultured heart cells is most likely a 
measure of creatine kinase S-thiolation in these cells. If 
that is true, experiments using the activity assay for 
S-thiolation of creatine kinase should be comparable to the 
experiment described in Figure II-4. 
The activity assay was used to determine the time course 
of S-thiolation of creatine kinase in diamide-treated heart 
cells to see if a second oxidative challenge produced a 
Figure 11-4. Effect* of diomide on S-thiolation of 4 different rat heart cell 
proteins. Heart cells radioactively labeled with 3Ss-cystine in 
the presence of cycloheximide were treated for the indicated times 
with 0.2 mH diamide and S-thiolation of soluble proteins was 
determined by the SDS-gel electrophoresis method previously 
described [7,8]. The autoradiogram from the gel was quantitatad 
and the radioactivity incorporated into 4 highly S thiolated bands 
was compared. Glutathione content of cell cultures was determined 
by HPLC 
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second S-thioiation episode. Heart cells were treated twice 
with diamide, once at the outset of the experiment, and again 
25 minutes later, as shown in Figure II-5. After 25 minutes 
it was thought that the cells would have recovered from the 
effects of the first diamide treatment. The initial diamide 
treatment caused 8% 5-thiolation of the creatine kinase and 
this had decreased to 4% by 25 minutes. The time course of 
this event was quite similar to the S-thiolation of the 
42 kDa protein in Figure II-4. The second diamide treatment 
caused the S-thiolation to increase from 4% to 20%, a much 
greater effect than the first challenge with diamide. Figure 
II-5B shows that the first diamide treatment produced 3.5 
nmole GSSG per mg protein in the cells, while the second 
treatment produced only 3.0 nmole GSSG per mg protein. Since 
there was some loss of glutathione from the cells during the 
first part of the experiment the GSSG to GSH ratio was 
greater after the second treatment (2.2) than after the first 
(1.2). Thus, while the absolute concentration of GSSG is 
slightly lower after the second treatment, the ratio of GSSG 
to GSH is higher. This higher ratio of GSSG to GSH may 
produce the increased S-thiolation. These results suggest 
that the amount of S-thiolation during an oxidative challenge 
may be related to the ratio of oxidized to reduced 
glutath i one. 
Figure II-5 Effects of two sequential additions of dianide 
on S-thiolation of heart cell creatine kinase. 
Heart cells were treated with 0.2 mH diamide at 
the beginning of the experiment and again 25 
minutas later. Creatine kinase S-thiolation 
(A) was determined by the activity assay and 
glutathione (B) was determined by HPLC 
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In our previous studies of heart cell S-thiolation, 
dianide but not t-butyi hydroperoxide caused a transient 
inhibition of cell beating C8]. Diamide also caused a much 
greater S-thiolation of the 42 kDa protein« now suggested to 
be creatine kinase, than did t-butyl hydroperoxide. Since 
creatine kinase is very important in heart energy metabolism, 
a study was undertaken to determine if creatine kinase 
inhibition by S-thiolation contributed to the effects of 
diamide on cell beating. Figure II-6 shows a comparison of 
cell beating and creatine kinase S-thiolation, determined by 
the activity assay, in heart cells treated with 0.2 mM 
diamide. Beating stopped within 5 minutes in this 
experiment, and creatine kinase did not reach its maximum 
S-thiolation until 10 to 15 minutes after addition of 
diamide. The cells resumed beating after 10 minutes, at a 
time when creatine kinase was still maximally S-thiolated. 
Since creatine kinase did not dethiolate before beating 
returned, creatine kinase was probably not directly 
responsible for the cessation of cell beating. However, 
S-thiolation of creatine kinase probably plays an important 
role in energy metabolism of these cells, and under other 
conditions, i.e., when maximum contractile activity is 
required, it may have an important role in cardiac cell 
contraction. 
Figure 11-6. Effeoto of dianide on beating and creatine kinase S-thiolation in 
neonatal heart cell cultures. Heart cell cultures were treated 
with 0.2 mM diamide and analyzed for either beating rate or -
creatine kinase S-thiolation at the time* indicated. Cell beating 
was determined by observation of a single cell culture. Each 
beating point is a single determination of beating rate. Creatine 
kinase S-thiolation was determined by the activity assay on 
triplicate cultures 
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Discussion 
Creatine kinase is an important enzyme in heart energy 
metabolism. Evidence suggests that the cytoplasmic and 
mitochondrial forms of creatine kinase are involved in an 
energy shuttle which uses creatine as a carrier of high 
energy phosphate from mitochondria to the myofibril 
[9,13,20-223. Most of the cytoplasmic form of creatine 
kinase is probably associated with various subcellular 
structures in. vivo C213. This form is responsible for the 
rapid regeneration of ATP from phosphocreatine and ADP at the 
organelles where ATP is utilized. The mitochondrial form is 
tightly bound to the outer surface of the inner mitochondrial 
membrane, and is responsible for producing phosphocreatine 
from ATP and creatine at the mitochondria. Under the 
conditions used in the present study, the rat heart 
mitochondrial isozyme should remain tightly bound [23], and 
only cytoplasmic forms of creatine kinase should be present 
in the extracts. Inhibition of either cytoplasmic or 
mitochondrial creatine kinase by S-thiolation has the 
potential of interfering with energy utilization by the 
myofibril. Only a small portion of the cytoplasmic creatine 
kinase became S-thiolated in diamide-treated cells, and a 
10-20% decrease in phosphoryl group transfer potential did 
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not significantly affect the beating rate of the ceils. 
These cells were not under any work load and therefore did 
not require maximal energy input for beating. The 10 to 20 % 
inhibition of creatine kinase in the present study could 
cause significant alterations in heart energy fluxes, but 
those decreases are only likely to be significant in a 
working heart. 
One example of a condition where S-thiolation of 
creatine kinase might produce significant metabolic effects 
is during reperfusion injury. The mechanism by which 
reperfusion damages myocardium involves a two-stage process 
in which intracellular reduced oxygen species play a small 
role. Extracellular reduced oxygen species, primarily 
superoxide, released by granulocytes, play a major role in 
tissue damage C243. It is not well understood how these 
reduced oxygen species effect protein metabolism. Metabolism 
of superoxide by superoxide dismutase produces hydrogen 
peroxide, and the primary pathway for elimination of hydrogen 
peroxide in cells is through glutathione peroxidase. 
Therefore, an influx of superoxide to the cells during 
reperfusion injury could lead to increases in GSSG and 
S-thiolation of proteins including creatine kinase. 
Depressed myocardial function has previously been 
associated with changes in creatine kinase during ischemia in 
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perfused rat heart [13]. In that study, a slight decrease in 
total creatine kinase and a loss of mitochondrial creatine 
kinase was seen during ischemia, with no further change in 
creatine kinase levels during reperfusion. The loss of 
mitochondrial creatine kinase correlated with depressed 
myocardial function. It is unclear whether these changes 
might be related to S-thiolation of either the mitochondrial 
or soluble enzyme. In an isolated heart preparation, the 
extent of S-thiolation during reperfusion might be less 
significant because the neutrophils, which contribute a great 
deal to the oxidative stress following reperfusion [24], are 
not present in an isolated perfused tissue. 
Two methods were presented in this study for 
determination of creatine kinase S-thiolation. Each method 
has certain advantages. The isoelectric focusing assay 
allows determination of the amount of each S-thiolated 
species present in a protein sample. It is also possible to 
determine the nature of the modifying thiol by this method, 
as previously demonstrated [15]. Thus, the isoelectric 
focusing method has several advantages in studies on the 
mechanism of S-thiolation. On the other hand, the activity 
assay measures creatine kinase S-thiolation directly under 
conditions where any possible artifactual S-thiolation is 
prevented. The method is very specific for the protein of 
94 
interest. It should be possible to develop activity assays 
for S-thiolation of a variety of proteins. Any protein which 
has one or more reactive sulfhydryls that are important for 
activity may be a candidate for a similar assay for 
S-thiolation. Both methodologies should prove useful in 
future studies of in vivo creatine kinase S-thiolation. 
Our studies have shown that cytoplasmic creatine kinase 
is one of the most easily S-thiolated proteins in heart. The 
slow rate of S-thiolation and dethiolation of this protein in 
vivo seems to be an exception when compared to eleven other 
soluble proteins. Since the enzyme seems to be quite 
reactive in. vitro, this slow reactivity may indicate that the 
sulfhydryl of creatine kinase is less available for 
modification in. vivo. The sulfhydryl is known to be located 
in an area of the protein involved in conformational changes 
[25], and the presence of substrates in, vivo might produce a 
conformation in which the sulfhydryl is less available. 
Creatine kinase is associated with various subcellular 
structures, and it is possible that this association limits 
the accessibility of the sulfhydryl to modification. Because 
of the central role of creatine kinase in heart energy 
metabolism, inhibition of this enzyme through S-thiolation 
may play an important role in damage to heart during 
oxidative stress. 
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DISCUSSION 
Oxidative atreaa, characterized by an increased 
concentration of reduced oxygen species in cells, is now 
recognized as an important aspect in a variety o£ disorders, 
including inflammation, aging, carcinogenesis, drug action, 
and heart disease. Oxygen-related damage to biological 
systems has been characterized using a variety of model 
systems. The only known mechanism by which oxidative stress 
can regulate cellular enzyme systems is through S-thiolation 
of proteins. The studies presented in this dissertation 
contribute to a better understanding of S-thiolation in 
several ways. Two agents commonly used to model oxidative 
stress in cells were shown to cause very different effects on 
heart cell beating and protein S-thiolation, though both 
produce similar effects on glutathione oxidation. New 
methods for studying S-thiolation of proteins were developed. 
One of these methods is specific for S-thiolation of creatine 
kinase. The occurrence of S-thiolated creatine kinase was 
demonstrated in diamide-treated cells, and the possible 
importance of creatine kinase S-thiolation was discussed. 
Prevention of artifactual thiol oxidation is of extreme 
importance in studies of protein S-thiolation and glutathione 
status during oxidative stress. In the present study, thiol 
oxidation was prevented during analysis of GSSG and 
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S-thiolated proteins by using NEM to block reactive 
sulfhydryls. This method is widely accepted [85-893. The 
assay method employed for determination of glutathione, the 
HPLC method of Reed et al. [1213, did not originally include 
steps to prevent artifactual formation of GSSG. The 
procedure was modified so that GSSG and total glutathione 
were determined in separate samples, and the samples for GSSG 
analysis were treated with NEM. The Appendix (Tables A-1 and 
A-2) contains additional information on the procedures that 
were used. This method was developed because the prevailing 
assay methods for GSSG, such as the widely used method of 
Tietze [85], all rely on the activity of glutathione 
reductase in the assay. Glutathione reductase is strongly 
inhibited by NEM even at low concentrations, so extensive 
sample preparation is required to remove residual NEM prior 
to enzymatic analysis of GSSG. The HPLC method does not 
require removal of NEM prior to analysis. In tissue 
extracts, the enzymatic method is more sensitive than the 
HPLC method, but in cell cultures radioactive labeling of the 
glutathione pool was used to enhance sensitivity. This makes 
the HPLC method much more sensitive in analysis of GSSG in 
cultured cells than the enzymatic method. Glutathione values 
of adult rat heart and neonatal heart cells obtained by this 
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method were in good agreement with values previously reported 
for rat heart (see Tables A-1, A-2, and £87,1173). 
Section I demonstrates that two compounds widely used to 
model oxidative stress, t-butyl hydroperoxide and diamide, 
produce markedly different effects in heart cells. Both 
diamide and t-butyl hydroperoxide produced extensive 
oxidation of glutathione (Tables I-l to 1-3). The effects of 
the two agents on S-thiolation of soluble proteins and on 
beating of heart cells were very different. t-Butyl 
hydroperoxide had no effect on beating for 15 to 20 minutes 
(Figure I-l), followed by an irreversible cessation of 
beating. This inhibition of beating may have been due to the 
ability of t-butyl hydroperoxide to readily form lipid 
peroxides. A recent review [122] indicates that organic 
peroxy radicals may be more important than superoxide or 
hydroxyl radicals in lipid peroxidation and toxic effects in 
cells. Diamide produced large amounts of GSSG, but its 
effects on beating were completely different from the effects 
of t-butyl hydroperoxide. Diamide caused a transient 
inhibition of beating almost immediately after cells were 
treated, but cells recovered and beat normally after diamide 
treatment. Thus, t-butyl hydroperoxide produced a toxic 
effect in cells which was not directly related to GSSG 
production, since this toxicity was not produced by diamide. 
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Diamide inhibits beating by a mechanism which was not 
directly related only to GSSG concentration, since t-butyl 
hydroperoxide did not produce this inhibition. 
The effects of diamide and t-butyl hydroperoxide on 
S-thiolation of proteins were also very different. Diamide 
S-thiolates proteins to a much greater extent than t-butyl 
hydroperoxide (Figures 1-2 to 1-4). The probable cause of 
the difference is the ability of diamide to react directly 
with protein sulfhydryls [123]. It has been stated that 
limiting the concentration of diamide eliminates the reaction 
with proteins [99,123]. The present data do not support this 
conclusion, since the pattern of protein S-thiolation 
produced by diamide differs from that produced by t-butyl 
hydroperoxide even at low diamide concentrations (Figure 
1-4). The idea presented in the discussion to Section I that 
reaction with membrane thiols might produce the beating 
inhibition is unlikely. In a recent experiment, heart cell 
cultures treated with 2, 10, or 25 mM 
5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) [1243 showed no 
effect on beating. This concentration should have 
S-thiolated cell surface sulfhydryl groups without entering 
the cell. Direct reaction with sulfhydryls was not 
determined, but the lack of effects on beating at high 
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concentrations indicates membrane sul£hydryl effects are 
unlikely. 
In Section II, new methods were developed for studying 
S-thiolation of proteins. The isoelectric focussing method 
was previously published [125]. That paper demonstrated use 
of the method in the determination of S-thiolation of 
purified proteins. The current paper used this method in the 
investigation of S—thiolation of creatine kinase in both 
bovine and rat heart. This method should prove generally 
useful in determination of S-thiolation of many proteins, 
especially if selective detection methods such as fluorescent 
antibodies are available. 
The activity assay for creatine kinase S-thiolation is a 
novel development of this study. The determination of 
S-thiolation of individual proteins under conditions which 
prevent artifactual S-thiolation has not been previously 
reported. This type of assay might be developed for a 
variety of enzymes, especially those which are inhibited by 
S-thiolation. 
During development of these assay methods it was 
desirable to determine if a single thiol blocking agent could 
be used for both the S-thiolation assay and the activity 
assay for creatine kinase S-thiolation. If this were 
possible, both assays could be done on a single sample. 
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The results of these studies are shown in the appendix. 
Figures A-1 to A-4. The thiol reagent of choice was NEM, 
since it has been shown to prevent artifactual S-thiolation. 
As shown in the appendix, NEM was unsuitable for use in the 
isoelectric focussing analysis. NEM caused a decrease in 
intensity of creatine kinase bands, and a shift toward a more 
akaline pi of the bands. The reactive sulfhydryl of creatine 
kinase is located in a region involved in conformational 
changes in the enzyme [126,127]. Reaction of NEM with this 
sulfhydryl may favor an altered conformation which differs in 
pi from the original band. The decreased intensity of the 
bands may indicate that several possible conformations with 
differing pi's occur, so that the protein no longer focuses 
as a single distinct band. 
The possibility of using iodoacetic acid or 
iodoacetamide in the activity assay for S-thiolation was also 
investigated. As shown in the appendix, these reagents were 
also unsuitable in the assay of creatine kinase. As a 
result, no single thiol blocking agent was useful in both 
systems, and separate samples were prepared for each 
analysis. 
The importance of S-thiolation of creatine kinase during 
oxidative stress has not been previously studied. The 
importance of this enzyme in supplying energy to the 
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contractile apparatus in heart was discussed in Section II. 
It has been calculated that over 99% of the high energy 
phosphate flux from mitochondria to the contractile apparatus 
in heart occurs by the creatine phosphate shuttle [128]. It 
is possible that S-thiolation of this enzyme plays a role in 
post-ischemic reperfusion injury in heart, since elevated 
creatine phosphate levels are detected during reperfusion 
[129]. The present study shows that the cytoplasmic form of 
creatine kinase becomes 5-thiolated in response to diamide. 
The mitochondrial form [130], which may be very important in 
regulation of mitochondrial respiration, was not studied. If 
the cytoplasmic form of creatine kinase was inhibited but the 
mitochondrial form was not, elevated concentrations of 
creatine phosphate would be expected. Inhibition of the 
cytyoplasmic form could have a great effect on available high 
energy phosphate in the cell. ATP levels are severely 
depressed in post-ischemic heart. Inhibition of cytosolic 
creatine kinase could decrease the rate at which the already 
diminished pool of ATP is regenerated from ADP. Thus, 
inhibition of creatine kinase by S-thiolation could play a 
major role in depressed myocardial function in oxidative 
stress. 
The presence of S-thiolated proteins in cells which were 
not under oxidative stress was studied. Basal S-thiolation 
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of proteins was very low in heart cells (see Appendix, Table 
A-5>. Both insulin and cyclic AMP have been proposed as 
regulators of protein S-thiolation, so effects of insulin and 
isoproterenol on glutathione oxidation and S-thiolation of 
proteins were studied. Insulin occaisionally produced some 
small increases in GSSG (Appendix, Table A-3). Isoproterenol 
did not produce increased GSSG (Appendix, Table A-4), and 
neither agent produced detectable increases in S-thiolation 
of proteins. The GSSG/GSH ratio was also unchanged in fasted 
or refed rats. Elevated levels of S-thiolated proteins were 
never seen in cells which were not subjected to an oxidative 
stress by diamide or t-butyl hydroperoxide. These studies 
provide no support for S-thiolation of proteins in regulation 
of metabolism except during oxidative stress in cells. 
The studies presented here add to the growing body of 
evidence that S-thiolation of proteins is important in 
regulation of cellular metabolism. It is probable that 
S-thiolation plays a key role in the integrated antioxidant 
defense of the cell. Through activation of glucose-6-
phosphate dehydrogenase and the pentose phosphate pathway, 
inhibition of energy utilizing processes, and activation of 
pathways which ultimately produce glucose-6-phosphate, 
S-thiolation provides a mechanism for activating cytosolic 
production of NADPH. Thus, S-thiolation of proteins provides 
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the key reductant for elimination of toxic reduced oxygen 
species during oxidative stress. 
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APPENDIX 
Introduction 
The purpose o£ the appendix is to present additional 
experimental work on S-thiolation of heart cell proteins 
which was not included in the research papers from Sections I 
and II, and which is relevant to the current discussion. 
Much of this work expands on material presented in one of the 
two research papers. When this occurs, reference will be 
made to the appropriate section. This section is a 
collection of many different ideas which do not have a single 
central theme. Each part of this section will present data 
on topics relevant to the discussion on protein S-thiolation, 
but not necessarily closely related to one another. 
Methodology 
Prevention of Artifactual S-Thiolation 
During development of the glutathione assay system and 
S-thiolation assays used in these experiments, many steps 
were taken to eliminate artifactual oxidation of thiols. The 
HPLC analysis of Reed et al. [121] was modified to allow 
accurate determination of GSSG in tissues, and samples for 
analysis of S-thiolated proteins were always treated with 
thiol blocking agents during extractions. The following 
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section presents the experimental work which lead to the 
selection of the conditions for analysis of both GSSG and 
S-thiolated proteins. 
Total glutathione content of tissues can be analyzed by 
a variety of methods [85-88,121]. Accurate determination of 
GSSG in tissues requires that steps be taken to prevent 
oxidation of GSH during sample preparation. The spontaneous 
oxidation of GSH to GSSG in air is slow. In tissue extracts, 
however, transition metal ions,, especially Fe+++, can 
catalyze air oxidation of GSH and other thiols. The most 
widely used procedure to prevent spontaneous oxidation of 
thiols involves rapidly blocking free thiols with N-Ethyl 
maleimide C853. NEM is preferred because it reacts rapidly 
with sulfhydryl groups at neutral pH, while both the 
oxidation of thiols and exchange between thiols and 
disulfides is more rapid at alkaline pH. Samples for 
analysis of GSSG or protein S-thiolaticn were therefore 
treated with NEM during extraction to insure accurate 
determinations. An NEM concentration of 50 mM was sufficient 
to block all artifactual oxidation of thiols in heart cell 
cultures. This concentration of NEM blocked all available 
GSH from heart cells (GSH was no longer detectable in HPLC 
samples) in less than 5 minutes, and also blocked more than 
99% of the reactive sulfhydryls of creatine kinase in 5 
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minutes, as measured by loss of enzyme activity. 50 mM NEM 
was also adequate to completely prevent artifactual 
S-thiolation in heart cell culture extracts prepared for 
SDS-polyacrylamide gel electrophoresis C13. 
Determination of Glutathione in Heart Tissue and Heart Cells 
Prior to using heart cell cultures as a model system for 
studies of protein S-thiolation, glutathione concentrations 
of heart cell cultures were compared to those of heart tissue 
to insure that cells in culture reflected the same oxidation 
status as intact tissue. During glutathione analysis of 
heart tissue, it was discovered that, unlike heart cell 
cultures, 50 mM NEM alone was insufficient to completely 
block GSH oxidation. Table A-1 shows the effects of more 
extensive treatments to prevent sulfhydryl oxidation during 
preparation of heart tissue. While NEM alone is quite 
effective in preventing GSH oxidation, both flushing the 
heart on a perfusion apparatus and treating with carbon 
monoxide act to reduce the amount of GSSG in tissue extracts. 
Both these treatments act to eliminate artifactual oxidation 
caused by hemoglobin [42]. 
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Table A-1. HPLC determination of GSH and GSSG in Heart 
Tissue. Female Sprague-Dawley rats were 
anesthetized with ether and hearts were rapidly 
removed. Where indicated, hearts were flushed of 
excess blood by perfusion via the aorta for less 
than 1 minute. Hearts were freeze-clamped and 
ground to a fine powder under liquid nitrogen. 
Treatment of hearts with CO in liquid N2 was 
performed as described by Veech et al.[42]. 
Heart powder was extracted in 5% PCA for total 
glutathione analysis, and duplicate aliquots were 
extracted in 5% PCA containing 50 mM NEM for GSSG 
analysis except for the -NEM sample. Samples 
were derivatized for HPLC analysis as described 
in text. Data are means ± standard deviations 
for the indicated number of samples 
Treatments Total* GSSG GSHb GSH/GSSG 
(nanomoles per milligram protein) 
-NEM (8)C 12 .4±0 .2 1 .2 ±0. 2 10. 0*0 .8 8.3*1.6» 
NEM only (8) 12 . 6±i .2 0 .20 dbO. 04 12. 2*1 .2 61 *14* 
CO+NEM (8) 12 .9*1 .0 0 .12 ±0. 04 12. 7*1 .0 104*35",** 
Flush+NEM (2) 14 .0*1 .0 0 .096*0. 015 13. 8*1 .0 144*25*** 
Flush+C0+NEM(4) 14 .0±0 .4 0 .087*0. 013 13. 8*0 .4 159*24**,*•* 
®Total = GSH + 2 x GSSG in PCA extracted samples. 
bGSH = Total - 2 x GSSG in NEM treated sample. 
^Number of samples in parentheses. 
•-NEM or Flueh+NEM or CO+NEM vs. NEM only, p<0.01. 
**CO+NEM vs. Flush+CO+NEM, p<0.1. 
***Flush+NEM vs. Flush+CO+NEM,p>0.1. 
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In Vivo Glutathione Status of Heart Cells 
Glutathione Oxidation in Normal Heart Cells 
In heart cell cultures, 50 mM NEM was sufficient to block 
GSSG formation during extraction of samples. Table A-2 shows 
GSH and GSSG concentrations from 4 separate heart cell 
preparations. The glutathione concentration and oxidation 
state was very similar in cultured heart cells to that which 
was found in intact tissue. The oxidation state and 
glutathione concentrations in heart tissue and in cultured 
heart cells were also in good agreement with the 
concentrations previously reported by Wendell [87] and by 
Ishikawa and Sies [117] for heart tissue. 
Effects of Insulin and Isoproterenol on Glutathione Oxidation 
in Heart CelIs 
In searching for a physiological condition in which 
S-thiolation of proteins might play a regulatory role, a wide 
variety of agents were tested for effects on glutathione 
oxidation in heart cells. Previous studies indicated that 
each of the agents tested might produce increases in GSSG and 
protein S-thiolation. Each agent will be discussed 
separately. 
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Table A-2. HPLC determination of GSH and GSSG in heart cell 
cultures. Heart cell cultures from 4 different 
heart cell preparations were assayed for 
glutathione. Medium was aspirated from 35 mm 
heart cell cultures, and cells were rapidly 
rinsed once with ice-cold medium and once with 
ice-cold phosphate-buffered saline. Cells were 
extracted with 100 ul 5% PCA for total 
glutathione analysis, and duplicate aliquots were 
extracted with 100 ul 5% PCA containing 50 mM NEM 
for GSSG analysis. Samples were derivatized for 
HPLC analysis as described in Section I. Data 
are means ± standard deviations for triplicate 
determinations 
Treatments Total® GSSG GSH^ GSH/GSSG 
(nanomoles per milligram protein) 
Experiment 1 14.11±0.23 0.059±0.018 13.99*0.23 237±72 
Experiment 2 12.03±0.90 0.062±0.010 11.90±0.90 186±32 
Experiment 3 12.54±0".ll 0.057±0.007 12.43±0.11 218±27 
Experiment 4 14.52±0.88 0.0s5±0.023 14.35±0.88 169±47 
®Total = GSH + 2 X GSSG in PCA extracted samples. 
bGSH = Total - 2 x GSSG in NEM treated sample. 
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Physiological responses to hydrogen peroxide and other 
agents which promote protein S-thiolation mimic many of the 
intracellular effects of insulin, including increased hexose 
transport and activation of the pentose phosphate pathway 
[107,108,131-1353. Membrane thiol groups have been reported 
to be oxidized by insulin, and insulin binding and 
internalization in cells is dependent on receptor thiol 
groups. A number of enzymes which catalyze thiol-disulfide 
interchange with insulin have been reported, including an 
insulin-GSH transhydrogenase [136] which could provide a 
mechanism for intracellular increases in GSSG in response to 
insulin. Intracellular hydrogen peroxide production in 
response to insulin has also been reported [137-139]. These 
studies prompted an investigation of whether insulin produced 
increases in GSSG in heart cells. 
In 4 experiments, heart cell cultures were treated for 10 
rain with concentrations of insulin from .01 to 100 mU/ml. 
GSH and GSSG were determined by the HPLC method described in 
Section I. Cellular response to insulin was measured by 
determining the activation of glycogen synthase. In two of 
the 4 experiments, no change in concentration of GSH or GSSG 
in the cells was detected. In two of the four studies, GSSG 
increased slightly in response to insulin. Table A-3 shows 
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Table A-3. Effects of Insulin on 6SSG concentrations and 
glycogen synthase activation in heart cell' 
cultures. Heart cell cultures were incubated 10 
minutes with the indicated concentrations of 
insulin. Glutathione was determined by the HPLC 
method described in Section I. Glycogen synthase 
was assayed by the method of Thomas et al. [140]. 
Glycogen synthase activation, termed "xl", was 
the ratio of activity assayed in the presence of 
14 mM sodium sulfate divided by the activity 
measured in the presence of 10 mM glucose-6-
phosphate 
Addition GSSG Glycogen 
picomoles / mg protein Synthase 
Experiment 1 
Nothing 58 a 25 ± 2 
Insulin: 0.01 mU/ml 55 ± 7 26 ± 2 
1 mU/ml 240 40 54 ± 7 
100 mU/ml 200 ± 10 49 ± 4 
Experiment 2 
Nothing 39 ± S 11 ± 2 
0.01 mU/ml 38 ± 10 11 ± 2 
O.l mU/ml 38 ± 5 12 ± 2 
1 mU/ml 41 ± 10 18 ± 3 
lO mU/ml 37 ± 8 20 ± 1 
100 mU/ml 45 ± 11 22 ± 2 
Experiment 3 
Nothing 59 ± 18 19 ± 2 
Insulin 10 mU/ml 104 ± 12 28 ± 4 
Experiment 4 
Nothing 41 ± 5 11 ± 1 
Insulin 10 mU/ml 42 ± 6 21 ± 2 
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the results of these experiments. When increases in GSSG 
occurred, they paralleled increases in glycogen synthase 
activity. GSSG increased a maximum of about 4-fold in cells 
treated with at least 1 mU/ml insulin. Total glutathione in 
these cells was unaffected by insulin. In several other 
experiments, no increase in S-thiolation of proteins could be 
detected in cells treated with insulin. In cells treated for 
24 hours with insulin no changes in the oxidation state of 
glutathione could be detected. These results lead to the 
conclusion that insulin could cause small increases in GSSG 
in cells, but increases in GSSG were not required for insulin 
function. Since no S-thiolation of proteins was detected, it 
is unlikely that protein S-thiolation plays a major role in 
regulation of metabolism by insulin. 
Studies by Isaacs and Binkley [90,913 in the mid 1970s 
indicated that rat liver contained large amounts of 
S-thiolated proteins, and that the concentrations of 
S-thiolated proteins varied diurnally and in response to 
glucagon and dibutyryl cyclic AMP. These studies have been 
widely cited. Unfortunately, efforts were not made to 
preclude artifactual S-thiolation during these studies. As a 
result, the high concentrations of S-thiolated proteins 
reported were probably also incorrect. The following studies 
were done to determine if cyclic AMP increases lead to 
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increases in glutathione oxidation or protein S-thiolation in 
heart. 
Isoproterenol is a beta adrenergic agonist. Beta 
adrenergic agonists produce cellular responses primarily 
through increases in cyclic AMP in the cell. Isoproterenol 
produces increases in cyclic AMP and increased beating rate 
in cultured heart cells within a few seconds after addition 
to the culture [141]. Concentrations of isoproterenol of 
between 10~® and 10"6 M are sufficient to produce 
physiological responses. Heart cell cultures were treated 
with 10~5 M isoproterenol, a concentration expected to 
produce maximal response in these cells, for either 5 minutes 
or 1 hour, and glutathione concentrations were determined. 
As shown in Table A-4 below, neither 5 minute nor 1 hour 
treatment with isoproterenol produced any significant changes 
in cell glutathione. 
S-Thiolation Analysis 
Basal Protein S-Thiolation in Heart Cells 
Many studies have indicated that a large portion of the 
glutathione pool of cells is bound to proteins (see €21 for a 
review). Most of these reports are erroneous, and are the 
result of failure of the investigators to prevent artifactual 
S-thiolation of proteins during sample preparation. Using 
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Table A-4. Effects of Isoproterenol on glutathione status of 
cultured heart cells. Heart cell cultures were 
t r e a t e d  f o r  t h e  t i m e s  i n d i c a t e d  w i t h  1 0 M  
isoproterenol. Glutathione was determined as 
described in Section I. Data are means ± 
standard deviations for triplicate determinations 
Addition Total Glutathione* 
(as GSH) 
nanomoles per mg protein 
GSSG 
Nothing 16.5 ± 2.5 0.030 ± 0.001 
10~S M Isoproterenol 
5 minutes 17.5 ± 1.9 0.035 ± 0.005 
1 hour 15.3 ± 3.5 0.029 ± 0.003 
®Total = GSH + 2 X GSSG in PCA extracted samples. 
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the SDS-polyacrylaraide gel electrophoresis method described 
in Section I, a study was undertaken to accurately determine 
the basal S-thiolation of heart cell proteins. To increase 
radioactive labeling of proteins, the specific activity of 
the 35s-cystine was increased lO-fold, to 1 x lO^l dpm/^mol. 
The dried gel and autoradiograro from the experiment were 
analyzed, and an estimate of the S-thiolation of several 
protein bands was determined. The estimation procedures were 
the same as those described in Section I for Table 1-4. 
Table A-5 shows the estimates of basal S-thiolation for the 
23, 35, and 42 kDa proteins from three cell cultures. The 
S-thiolation of these proteins and all other proteins in the 
samples was very low. In no experiment were high 
concentrations of S-thiolated proteins found in untreated 
cells. The basal S-thiolation of soluble proteins is 
probably always less than 1% in heart cells. 
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Table A-5. Basal S-thiolation o£ heart cell proteins. 
S-Thiolation of heart cell proteins from cells 
not treated with agents to oxidize cellular 
glutathione was determined by the 
SDS-polyacrylamide gel electrophoresis method 
previously described (E13 and Section I) 
Protein Band Picomoles Fémtomoles S-thiolation 
Protein GSH Protein 
per band per band ^SH/subunit 
23 kDa 2T7 2.5 ± 0.3 0.00093 ± 0.00011 
35 kDa 3.0 2.6 ± 0.5 0.00087 ± 0.00018 
42 kDa 5.0 2.1 ± 0.4 0.00041 ± 0.00007 
Choice of Thiol Blocking Agents in S-Thiolation Analysis 
Effects of Thiol Reacrent Concentration on Determination of 
Creatine Kinase S-thiolation by Isoelectric Focusing 
For the isoelectric focusing assay for S-thiolation to 
be accurate, it is necessary that the thiol reagents used to 
block free sulfhydryls react quickly and completely, so that 
variations in sample preparation will not effect the assay. 
To assure that iodoacetamide and iodoacetic acid were 
reacting completely and uniformly, the experiment in Figure 
A-1 was done. Samples of S-thiolated bovine heart extract 
were treated with various concentrations of either 
iodoacetamide or iodoacetic acid. After 15 minutes, half of 
Figure A-1. Effects of thiol reagent concentration on isoelectric focusing 
analysis of creatine kinase S-thiolation. Bovine heart extract was 
incubated 30 minutes with 50 nM GSSG to S-thiolate creatine kinase. 
(A) Samples were treated 15 minutes at pH 6 with indicated 
concentrations of lodoacetanlda or lodoacetic acid. <B) Samples 
were treated aa in (A). After 15 minutes, 50 mM lodoacetic acid was 
added to samples treated with iodoacetamide, and 50 mM iodoacetamide 
was added to samples treated with lodoacetic acid. Samples were 
incubated an additional 15 minutes. All samples were focused on a 
pH 5-6 gel 65 minutes 
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each sample was treated with the thiol reagent not used in 
the first treatment at a concentration of 50 mM. The other 
half of the sample was not treated. If the initial reaction 
was not complete by the end of the first incubation, the 
second compound should react with the available sulfhydryl 
groups and alter the isoelectric focusing pattern of the 
bands. As shown in Figure A-IA, concentrations of 
iodoacetamide from 2 mM to 50 mM gave identical results, 
indicating that 2 mM iodoacetamide was sufficient to block 
the available creatine kinase sulfhydryls. The same was true 
for 2 to 50 mM iodoacetic acid. In Figure A-IB, when 50 mM 
iodoacetic acid was added to samples previously treated with 
2 to 50 mM iodoacetamide, the samples focussed identically to 
those from A-IA, indicating the reaction of the iodoacetic 
acid was complete in less than 15 minutes and all available 
sulfhydryls were completely blocked. The same was true in 
samples treated with 2 to 50 mM iodoacetic acid, followed by 
50 mM iodoacetamide. Thus, iodoacetamide and iodoacetic acid 
reacted rapidly and completely with the sulfhydryls of 
creatine kinase. The reaction was not sensitive to 
variations in concentration between 2 and 50 mM. This 
indicates these compounds are fully suitable for use as thiol 
blocking agents in S-thiolation analysis by isoelectric 
focusing. 
133 
Choice o£ Thiol Reagents in Analysis o£ Creatine Kinase 
S-Thiolation 
The two assay methods for analysis of the S-thiolation 
of creatine kinase, isoelectric focusing and the "activity 
assay", both required a thiol reagent to rapidly block free 
sulfhydryl groups. To simplify sample preparation, it was 
desirable to utilize a single agent for both analyses, so 
experiments were undertaken to determine if either NEM or 
iodoacetamide could be utilized in both analyses. 
N-Ethyl maleimide was the thiol agent of choice because 
it reacts rapidly with thiols at neutral pH, while the 
exchange reaction between thiols and disulfides is slow at 
neutral pH. NEM worked well in the activity assay for 
S-thiolation (see Section II). To determine if NEM was 
suitable for use with the isoelectric focusing analysis 
system, S-thiolated bovine heart extracts were treated with 
either 50 mM iodoacetamide or various concentrations of NEM, 
and the samples were compared by isoelectric focusing. The 
results of this procedure is shown in Figure A-2. When 
samples treated with NEM were focused, several changes 
occurred in the creatine kinase bands. The reduced enzyme 
band focused at a more alkaline pH than in iodoacetamide 
treated samples. The bands from the samples treated with NEM 
were less intense than in the sample treated with 
Figure A-2 A comparison of NEM and iodoacetamide in 
S-thiolation analysis by isoelectric focusing. 
Bovine heart extract was S-thioiated by 
incubation 30 minutes with SO mM GSSG and 
aliquots were treated with either SO mM 
iodoacetamide or indicated concentrations of NEM 
10 minutes at room temperature. Samples were 
focused 65 minutes on a pH 5-8 lEF gel. 
a.Creatine kinase which was not S-thiolated. 
b.Creatine kinase S-thiolated by one glutathione 
per dimer. 
c.Creatine kinase S-thiolated by two glutathiones 
per dimer 
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iodoacetamide, and the density was inversely proportional to 
the concentration of NEM used. The relative intensity of the 
three bands also changed, with the non-S-thiolated bands 
losing intensity faster than the S-thiolated bands. Because 
the relative intensities of the bands change, the calculated 
S-thiolation for samples treated with NEM was 
higher than the S-thiolation calculated for samples treated 
with iodoacetamide, and the S-thiolation calculated in NEM-
treated samples varied with the concentration of NEM used. 
At low concentrations of NEM, the calculated value for 
S-thiolation approached the correct value from the 
iodoacetamide-treated sample. Because of these problems, NEM 
was unsuitable for use in isoelectric focusing assays. 
The thiol reagents iodoacetic acid or iodoacetamide 
could not replace NEM in the activity assay for creatine 
kinase S-thiolation. (See Section II for details of the 
activity assay for S-thiolation). The amount of activity 
recovered in the S-thiolation assay decreased with increasing 
concentrations of either iodoacetic acid or iodoacetamide, as 
shown in Figure A-3. This inactivation was not due to 
alkylation of groups other than the most reactive sulfhydryl 
since, if this occurred with iodoacetic acid, it would impart 
additional negative charges to the protein which would lead 
to multiple bands in the samples treated with iodoacetic acid 
Figure A-3. A comparison of thiol reagents in the activity 
assay for creatine kinase S-thiolation. Rat 
heart extracts were S-thiolated by 30 minute 
incubation with 25 mM GSSG. N-Ethylmaleimide 
(NEM), iodoacetamide (lAm), or iodoacetic acid 
(lAA) neutralized with tris base were added' in 
the concentrations indicated and allowed to react 
15 minutes at room temperature. All samples were 
diluted 100-fold in 50 mM HEPE5-K0H, pH 7.4, 1 
mg/ml BSA, 20 mM DTT, and allowed to react 15 
minutes at room temperature. Samples were kept 
on ice until assay 
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in the isoelectric focussing procedure. These bands were not 
present (see Figure A-1). Control experiments showed there 
was no interference by iodoacetic acid or iodoacetamide with 
the assay system under the conditions used in the experiment. 
It seems likely that the inactivation results from iodination 
of some group by the I~ released during hydrolysis of 
iodoacetic acid or iodoacetamide. An active site histidine 
has been postulated both on the basis of kinetic evidence 
[142] and NMR studies [143] and this residue is a likely 
target for iodination by I". 
The result of these studies was that a single sulfhydryl 
blocking agent was not suitable for both assay system. As a 
result, in all determinations where both the activity assay 
and the isoelectric focusing assay were used, separate 
samples were prepared for each method. 
Variability in Cell Preparation 
Variability Between Heart Cell Preparations 
Individual heart cell preparations responded uniformly 
to a variety of stimuli (see Sections I and II). When 
experiments were done on different preparations of cells, 
however, the preparation often responded quite differently. 
Figure A-4 illustrates this variability. Heart cell cultures 
from two different preparations were treated with 
Figure A-4. Effects of diamide on beating and creatine kinase 
S-thiolation in neonatal heart cell cultures. 
Heart cell cultures were treated with 0.2 mM 
dianide and analyzed for either beating rate or 
creatine kinase S-thiolation at the times 
indicated. Cell beating was determined by 
observation of a single cell culture. Each 
beating point is a single determination of 
beating rate. Creatine kinase S-thiolation was 
determined by the activity assay on triplicate 
cultures. .A and B are identical experiments on 
cells from two different preparations. 
X 
BEATS PER MINUTE ••• 
% S-THIOLATION % S-THIOLATION 
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200 juM diamide, and cell beating and creatine kinase 
S-thiolation were determined. The effect of diamide on both 
creatine kinase S-thiolation and cell beating varied between 
preparations of cells. In Figure A-4A, the cells did not 
stop beating until 5 minutes after addition of diamide, and 
resumed beating less than 4 minutes later. These cells 
resumed their original beating rate less than 30 minutes 
after diamide treatment. In contrast, the cells in Figure 
A-4B stopped beating in 2.5 minutes, resumed beating after 15 
minutes, and did not reach their original beating rate until 
60 minutes after treatment with diamide. In Figure A-4A, 
creatine kinase was about 10% S-thiolated in response to 
diamide, and the S-thiolation decreased rapidly after 
reaching its peak 10 minutes after diamide treatment. In 
Figure A-4B, the maximum S-thiolation of creatine kinase was 
about 12%, but the S-thiolation did not decrease 
significantly during the 25 minute experiment. Diamide had a 
greater effect on beating and on creatine kinase S-thiolation 
in the experiment shown in Figure A-4B than it did in the 
experiment shown in Figure A-4A. These differences are 
probably due to differing cell density in the two heart cell 
preparations, with the cells in the experiment shown in part 
A more dense than those in part B. This would result in an 
increased ability of the cells in A to reduce the oxidation 
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produced by diamide, resulting in a decreased effect of 
diamide on both S-thiolation and beating of the cells. This 
same sort of variability was shown in the glutathione 
analyses in Tables I-l to 1-3. As a result of this inherent 
variability in the heart cell cultures, direct comparison of 
experimental effects in heart cells were always done on cells 
from the same preparation. Comparisons between different 
preparations of cells could yield useful qualitative 
information but could not be used for direct quantitative 
comparisons. 
